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1. Summary 
The human -herpesvirus varicella-zoster virus (VZV) causes chickenpox during primary 
infection and shingles upon reactivation from its latent state in sensory ganglia. Shingles are 
often associated with severe pain that can persist as postherpetic neuralgia. In order to 
facilitate the investigation of VZV, we constructed the genomes of the VZV strains P-Oka 
and HJO as infectious F-factor-derived bacterial artificial chromosomes (BACs). These two 
VZV BACs (pP-Oka and pHJO) can be seamlessly manipulated by versatile recombination 
techniques in Escherichia coli and subsequently delivered into VZV-permissive eukaryotic 
cells to allow the reconstitution of infectious mutant virus. 
In this work, the two different VZV BACs were engineered in E. coli to induce the seamless 
removal of the bacterial mini-F sequences upon virus reconstitution in VZV-permissive cells 
via novel replication-based strategies. In pP-Oka-derived virus, the mini-F sequences were 
efficiently released by homologous recombination of a stabilized inverse genomic duplication 
inserted into the bacterial vector elements. In contrast, this system was ineffective in virus 
progeny recovered from pHJO. To increase the efficiency of the vector elimination upon virus 
reconstitution from the cloned HJO genome, the mini-F sequences were precisely and 
seamlessly transposed within the viral DNA via a novel synchronous Red-recombination 
reaction in E. coli, whereby six different BAC variants were generated. The insertion of the 
mini-F sequences directly between the genomic termini resulted in a BAC derivate, of which 
the vector elements were autonomously and efficiently released during the virus recon-
stitution even without a genomic duplication. In addition, the derived progeny exhibited 
genome properties and replication kinetics virtually identical to that of the wild-type virus.  
In conclusion, the pP-Oka BAC with an inverse genomic duplication and the BAC variant of 
pHJO with terminal integrated mini-F vector are two optimized constructs to rapidly generate 
VZV mutants without leaving behind any operational sequences. Moreover, the mini-F vector 
transposition reaction eliminates the last hurdle to perform virtually any kind of imaginable 
targeted and seamless BAC modifications in E. coli. Thus, the newly developed manipulation 
techniques can be useful to optimize, repair, or restructure other established BACs as well, 
not even for the specific research field of herpesviruses, which may facilitate the development 
of gene therapy and vaccine vectors. 
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2. Zusammenfassung 
Das menschliche -Herpesvirus Varicella-Zoster-Virus (VZV) verursacht Windpocken bei 
der Primärinfektion und Gürtelrose bei der Reaktivierung aus der Latenz in sensorischen 
Ganglien. Die Gürtelrose ist häufig mit schweren Schmerzen verbunden, die als postherpeti-
sche Neuralgie persistieren können. Um die Erforschung von VZV zu erleichtern, klonierten 
wir die Genome der VZV-Stämme P-Oka und HJO als infektiöse, F-Plasmid-abgeleitete 
bakterielle artifizielle Chromosomen (BACs). Diese beiden VZV-BACs (pP-Oka und pHJO) 
können durch vielseitig anwendbare Rekombinationstechniken in Escherichia coli nahtlos 
manipuliert und anschließend in VZV-permissive eukaryote Zellen transfiziert werden, um 
die Rekonstitution von infektiösen Virusmutanten zu ermöglichen. 
In dieser Arbeit wurden die beiden unterschiedlichen VZV-BACs in E. coli verändert, um die 
nahtlose Entfernung der bakteriellen Mini-F-Sequenzen nach der Virusrekonstitution durch 
neuartige Replikationsstrategien zu induzieren. Bei aus pP-Oka hergestelltem Virus wurden 
die Mini-F-Elemente durch homologe Rekombination einer inversen stabilisierten geno-
mischen Duplikation im bakteriellen Vektoranteil effizient entfernt. Im Gegensatz dazu war 
dieses System in Viren hergestellt aus pHJO ineffektive. Um die Effizienz der Vektor-
elimination nach der Virusrekonstitution aus dem klonierten HJO-Genom zu verstärken, 
wurden die Mini-F-Sequenzen durch eine neuartige, synchrone Red-Rekombinationsreaktion 
in E. coli innerhalb der viralen DNA transponiert, wodurch sechs verschiedene BAC-
Varianten konstruiert wurden. Die Insertion der Mini-F-Sequenzen direkt zwischen die 
Genomenden resultierte in einer BAC-Variante, von der die Vektorsequenzen autonom und 
effizient nach der Virusrekonstitution entfernt wurden, auch ohne genomische Duplikation. 
Zudem zeigten die hergestellten Viren Genomeigenschaften und Replikationskinetiken, die 
mit denen vom Wildtyp-Virus identisch waren. 
Der pP-Oka BAC mit inverser genomischer Duplikation und die BAC-Variante von pHJO mit 
terminal integriertem Mini-F-Vektor sind somit zwei optimierte Konstrukte zur schnellen 
Herstellung von Virusmutanten, ohne irgendwelche Fremdsequenzen zu hinterlassen. Zudem 
eliminiert die Mini-F-Transpositionsreaktion die letzte Hürde um jede vorstellbare, nahtlose 
BAC-Modifikation in E. coli durchzuführen. Die neuentwickelten Manipulationstechniken 
können somit nützlich sein um auch andere etablierte BACs zu optimieren, reparieren oder 
restrukturieren, nicht nur für das spezielle Forschungsgebiet der Herpesviren, was die Ent-
wicklung von Gentherapie- oder Impfstoffvektoren erleichtern könnte. 
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3. Introduction 
3.1 The varicella-zoster virus 
The neurotropic human -herpesvirus varicella-zoster virus (VZV) is the etiological agent of 
varicella and herpes zoster, commonly termed chickenpox and shingles (Garland, 1943; 
Hope-Simpson, 1954; Steiner, 1875; von Bokay, 1909; Weller et al., 1958). Primary infection 
with VZV results in varicella, which is most prevalent in childhood and usually characterized 
by fever and a generalized pruritic dermatomal rash (Grose, 1981). VZV disseminates in a 
cell-associated viremia throughout the human body, to invade the skin, mucous membranes, 
and visceral and nervous tissue (Grose, 1981; Jones and Arvin, 2006; Ku et al., 2005; Ku et 
al., 2004). During primary infection, VZV establishes life-long latency of episomal viral 
genomes in the nucleus of sensory neurons especially of the dorsal root and trigeminal ganglia 
(Head et al., 1997; Kennedy et al., 1998; Laguardia et al., 1999). In immunocompromized 
patients or in elderly people, VZV can be reactivated from its latent state by undefined stimuli 
and provoke herpes zoster, a dermatomal rash that is largely confined to regions of the skin 
served by a single sensory nerve. Herpes zoster is associated with acute and often severe, 
long-lasting pain that can persist as postherpetic neuralgia (Annunziato et al., 2000; Hope-
Simpson, 1965; Schmidt et al., 2003).  
Infectious cell-free virus particles are released from the human body during varicella and 
herpes zoster only after lytic replication in the cutaneous epithelium or in respiratory mucous 
membranes (Chen et al., 2004). Since the respiratory secretions from patients with chicken-
pox and shingles allow the airborne transmission of the virus, approximately 95% of the 
population in temperate climates are latently infected with VZV at the age of 20-29 years 
(Cohen et al., 2007; Sawyer et al., 1994). The live-attenuated vaccine Oka (V-Oka), which 
has become publicly recommended for infants and susceptible older children and adults in 
several countries, including Germany, has greatly reduced the morbidity and fatality rates of 
VZV infection (Hambleton and Gershon, 2005; Krause and Klinman, 1995; Krause and 
Klinman, 2000; Takahashi et al., 1974). In addition, a high-dosage vaccine administration 
strategy has also been shown to reduce the zoster morbidity in latently infected healthy adults 
of 60 years or older (Oxman and Levin, 2008; Oxman et al., 2005; Sperber et al., 1992). 
In the herpesviridae family (gr. herpein, to creep), VZV is classified as a member of the 
genus varicellovirus within the alphaherpesvirinae subfamily (Cohen et al., 2007). VZV and 
the two closely related herpes-simplex viruses HSV-1 and HSV-2 are the only human-patho-
genic members of the -herpesviruses which share the ability to establish primarily but not 
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exclusively life-long latency in sensory nerve ganglia. In contrast to HSV, VZV has a narrow 
host range, restricted to selected cell types of human or simian origin. The genomic arrange-
ment as well as the ability to disseminate widely through the natural host assigns VZV toge-
ther with pseudorabies virus (PRV), equine herpesvirus type 1 (EHV-1), bovine herpesvirus 
type 1 (BoHV-1), or simian varicella virus into the genus varicellovirus (Cohen et al., 2007). 
3.1.1 Structure of the virus particle 
The highly cell-associated replication of VZV in vivo as well as in vitro has continuously 
impaired the investigation of the virus, primarily because of the inability to obtain substantial 
amounts of cell-free intact viral particles in tissue culture (Chen et al., 2004; Harson and 
Grose, 1995; Weller, 1953). Although it has been demonstrated that the VZV particle 
comprises the typical components of a mature herpesviral virion, its final structural descrip-
tion has been deduced by analogies mainly to HSV-1 (Figure 1) (Cohen et al., 2007). 
 
Figure 1. Virion structure of VZV. A) Electron microscopic appearance (Cohen et al., 2007) and B) schematic 
overview of the mature VZ virion particle.  
The VZ virion core contains a single copy of the linear double-stranded DNA (dsDNA) 
genome, which appears to be suspended on a fibrillar protein spindle (Furlong et al., 1972; 
Puvion-Dutilleul et al., 1987). The particle core is encased by the nucleocapsid, an icosahed-
ron of 12 pentameric and 150 hexameric protein capsomers. The capsid is 80 to 120 nm in 
diameter (Almeida et al., 1962). An amorphous protein matrix, the tegument, which is unique 
for the herpesviridae family, connects the nucleocapsid with the viral envelope and contains 
structural components as well as regulatory proteins that immediately take control of the host 
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environment after infection (Kinchington et al., 1995; Kinchington et al., 1992; Stevenson et 
al., 1994). The virus envelope consists of a double lipid membrane which is derived from 
cellular vesicles and decorated with various VZV-specific glycolproteins during the virion 
maturation process. The mature, spherical infectious VZV particle is pleomorphic and 
measures 180 to 200 nm in diameter (Figure 1) (Almeida et al., 1962).  
The 125,000 bp linear dsDNA genome of VZV can be subdivided into two covalently linked 
components of varying length, each comprising a unique region flanked by inverted repeats 
(Figure 2) (Davison and Scott, 1986). The long component (L) consists of a unique long 
region (UL, 105,000 bp) bracketed by very small repeats (TRL, terminal repeat long; IRL, 
internal repeat long; 88.5 bp). The short (S) component includes a unique short region (US, 
5,232 bp) flanked by very large repeats (IRS, internal repeat short; TRS, terminal repeat short; 
7,319.5 bp) (Figure 2) (Davison and Scott, 1986). Five repetitive regions, termed R1 to R5, 
contain variable numbers of serially repeated short sequences and are distributed over the 
viral genome in the unique as well as in the repeat regions. The VZV genome has a GC base 
pair content of 46%, which is higher for the repeat elements in comparison to the unique 
segments, being 59% for the large S repeats and even 68% for the small L repeats (Davison 
and Scott, 1986). Both 3‟-ends of the linear dsDNA genome terminate with a single unpaired 
G or C overhanging nucleotide (Davison, 1984). Despite of the extensive repeat sequences 
and although a number of different VZV genotypes have been identified, the genome shows a 
high degree of genetic stability upon propagation in vitro (Straus et al., 1983).  
 
Figure 2. Genome organization of VZV. The genome of VZV consists of a long (L) and a short (S) component 
(dotted lines), comprising a unique long (UL) or a unique short (US) region flanked by very short (TRL, terminal 
repeat long; IRL, internal repeat long) or large (IRS, internal repeat short; TRS, terminal repeat short) inverted 
repeats, respectively.  
The VZV DNA is densely packed with open reading frames (ORF) of a least 71 specific 
genes (Davison and Scott, 1986). Three genes are present twice within the viral DNA, since 
they are located within the large S repeats, and one ORF (ORFS/L) is additionally constituted 
at the terminal genomic junction of the S and L component upon circularization of the VZV 
molecule during the viral DNA replication (Davison and Scott, 1986; Kemble et al., 2000). 
Hybridization and sequence analysis have revealed that the VZV genome shares extensive 
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colinearity with that of HSV-1, aiding for the prediction of specific gene and DNA element 
functions by analogy (Davison and Wilkie, 1983; McGeoch et al., 1988; McGeoch et al., 
1985; McGeoch et al., 2006). Based on amino acid sequence comparison, 64 genes of VZV 
have HSV-1 homologs, 4 ORFs have EHV-1 or EHV-4 homologs, and one coding domain 
has a homolog in the -herpesvirus Kaposi's sarcoma-associated herpesvirus. At least 40 
genes of VZV, which encode mainly viral enzymes and structural proteins, appear to be 
conserved throughout the human-pathogenic herpesviruses (Cohen et al., 2007). Although 
genes spanning the genomic termini have been found in some other herpesvirus genomes, a 
homolog for the VZV S/L protein has not been determined via the available sequence 
databases (Kemble et al., 2000). 
3.1.2 Life cycle of the virus  
As for all other -herpesviruses, the initial attachment of VZV to the host cell appears to be 
mediated by non-specific electrostatic interactions between the viral glycoproteins and 
cellular surface glycosaminoglycans such as heparan sulfate (Jacquet et al., 1998; Zhu et al., 
1995). Insulin-degrading enzyme has been identified as a specific cellular receptor for VZV, 
whereby it has not been clarified whether this interaction triggers the viral entry on the cell 
surface or in endosomes after virus endocytosis (Figure 3) (Li et al., 2006). In addition, the 
entry of cell-free virus particles into the cytoplasm seems to be significantly facilitated by the 
interaction of phosphorylated N-linked oligosaccharides on VZV viral glycoproteins with the 
cation-independent mannose 6-phospahte receptor (MPR
ci
) (Chen et al., 2004). It is not yet 
well investigated for VZV how the de-enveloped capsids are transported after virus entry 
through the cytoplasm and translocated into the nucleus, and how the genome is released into 
the nucleoplasm. It has been shown for HSV-1 that the entered capsids are transported along 
microtubules by dynein/dynactin motor protein complexes through the cytoplasm and bind to 
nuclear pores, where they are degraded concomitantly with the release of their DNA content 
into the nucleus (Dohner et al., 2002; Ojala et al., 2000). 
All evidence suggests that the VZV transcription program is coordinated similarly to that of 
HSV-1 (Cohen et al., 2007). Specific regulatory tegument proteins that were released into the 
cytoplasm after virus entry and transported into the nucleus are assumed to initiate or promote 
the transcription of the VZV immediate early (IE) genes (Defechereux et al., 1997; Forghani 
et al., 1990; Kinchington et al., 1995; Kinchington et al., 1992). The resulting IE messenger 
RNAs (mRNAs) are transported into the cytoplasm, translated, and the synthesized IE 
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proteins are translocated back into the nucleus to initiate the transcription of the early (E) 
genes. The derived E proteins then support or enhance the activation of the transcription of 
the late (L) genes in an analogous way (Figure 3). In this temporally coordinated expression 
cascade, the IE proteins have mainly regulatory functions, the E products especially constitute 
the DNA-replication machinery, and the L genes encode nearly exclusively structural compo-
nents for nucleocapsid and subsequent virion assembly (Cohen et al., 2007). Unlike HSV-1 
latency, where only one type of non-translated transcripts is detectable, protein products of six 
genes are expressed during the latent state of the VZV genome (Croen et al., 1988; 
Mahalingam et al., 1993; Mahalingam et al., 1990). 
 
Figure 3. Replication cycle of VZV. The model of the VZV replication cycle is adapted to a scheme from 
Cohen et al. (Cohen et al., 2007). First, the virion attaches to the host cell. Following that, the nucleocapsid 
together with the tegument proteins is released into the cytoplasm upon receptor-mediated membrane fusion on 
the cell surface or within endosomes after internalization of the virus particle. The nucleocapsid and specific 
tegument proteins are transported into the nucleus, where the viral genome is released. Immediate-early (IE), 
early (E), and late (L) mRNAs and proteins are synthesized and the viral DNA is packaged into pre-assembled 
nucleocapsids. The capsids are enveloped and de-enveloped as they traverse the nuclear membranes and then re-
enveloped and decorated with glycoproteins as they bud into membrane vesicles from the trans-Golgi network 
(1). In an alternative model, the capsids are enveloped as they bud into the perinuclear space, transported through 
the cytoplasm in vesicles budded from cisternae of the rough endoplasmic reticulum and decorated with 
glycoproteins after membrane fusion of the virus-laden vesicles with glycoprotein-laden microvesicles from the 
trans-Golgi network (2). In both pathways, the particles are either diverted in vesicles to prelysosomes and 
subjected to degradation, or transported to the cell surface and released from the cell as mature virions. 
Two competing pathways for VZV assembly and egress have been favoured from studies 
with VZV-infected human tissues and cells in culture that illustrate the virus tegumentation, 
envelopement process, degradation and release in vivo and in vitro (Cook and Stevens, 1968; 
Gabel et al., 1989; Gershon et al., 1973; Gershon et al., 1994; Harson and Grose, 1995; Jones 
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and Grose, 1988). One model postulates that VZV capsids acquire the tegument in the 
nucleus, are enveloped during the transit through the inner nuclear membrane, and traverse 
the cytoplasm in vesicles budded from cisternae of the rough endoplasmic reticulum (Figure 
3). Microvesicles born from the trans-Golgi network (TGN) subsequently release their 
content upon membrane fusion into the virus-laden vesicles and the available VZV-specific 
glycoproteins decorate the viral envelope. The evolving particles are then transported in large 
cytoplasmic vesicles to the cell surface and released by exocytosis into the extracellular 
environment (Figure 3) (Harson and Grose, 1995; Jones and Grose, 1988). In the second 
model, the nucleocapsids receive an initial tegument layer within the nucleus and acquire and 
lose an envelope as they transit through the inner and outer nuclear membrane into the 
cytoplasm (Figure 3). The de-enveloped capsids interact via additional tegument proteins with 
cytoplasmic tails of VZV-specific glycoproteins exposed on membranes of TGN cisternae, 
and are then re-enveloped by invagination into TGN-budded vesicles. The derived particles 
with glycoprotein-decorated envelopes are then transported in vacuoles to the cell surface and 
released by exocytosis as mature virions into the extracellular space (Figure 3) (Gershon et 
al., 1973; Gershon et al., 1994). 
VZV remains tightly associated with cells in culture, as most of the viral particles undergo 
degradation in the cytoplasm before they are assembled and released as infectious mature 
virions (Grose, 1990; Taylor-Robinson, 1959; Weller, 1953). The majority of the cytoplasmic 
particles in cell culture develop deformed dense cores and fragmented membranes, and 
virions harvested from supernatants often have incomplete envelopes and teguments, or even 
empty nucleocapsids (Caunt and Taylor-Robinson, 1964; Cook and Stevens, 1968; Grose, 
1990; Harson and Grose, 1995). Recently, it has been demonstrated that on average 40,000 
VZV particles from culture supernatants are required to generate one infection in monolayers 
of permissive cells, whereas only 10 units are sufficient to support HSV-1 propagation in 
vitro (Carpenter et al., 2009). Primary cells or cell lines are not available for yielding 
substantial amounts of cell-free intact VZV in culture (Grose et al., 1979; Harper et al., 1998; 
Harson and Grose, 1995). Consequently, VZV is usually propagated in vitro by dispersing 
infected cell monolayers and passaging them onto uninfected cells (Cohen et al., 2007). 
Considering the highly cell-associated nature in cell culture and the efficient release of mature 
particles from infected individuals, it has to be envisaged that VZV has different growth 
properties in vitro and in vivo at least in concern of certain cell-types of the human body. Cell 
culture studies demonstrated that VZV assembly usually ends up in MPR
ci
-receptor- 
dependent diversion of the virus-laden vesicles into prelysosomes, where the viral particles 
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are subjected to enzymatic degradation (Figure 3) (Chen et al., 2004; Gabel et al., 1989; 
Gershon et al., 1994). MPR
ci
-receptor-deficient cells release cell-free intact VZV virions 
much more efficiently than their non-mutated progenitors. Moreover, it was found that 
superficial epidermal cells in fact lack the MPR
ci
-receptor, which may account for the high 
amount of infectious cell-free VZV particles in vesicular fluids (Chen et al., 2004).  
3.1.3 Replication of the viral genome 
A model for the mechanisms and intermediates of the VZV DNA replication and maturation 
process has been predominantly deduced from the sequence, the different arrangements, and 
especially from the structure of the termini of the viral genome (Davison, 1984; Davison and 
Scott, 1986; Ecker and Hyman, 1982; Kinchington et al., 1985). Immediately after release 
into the nucleus, the linear dsDNA genome of VZV circularizes, which is assumed to be 
mediated or supported by the ligation of the single 3‟-overhanging nucleotides at the viral 
DNA ends (Garber et al., 1993; Kinchington et al., 1985; Nagaike et al., 2004). Initially, the 
resulting covalently closed genome is thought to be bidirectionally replicated from one or 
both origins of DNA replication within the large S repeats into circular catenated molecules 
(Boehmer and Villani, 2003; Stow and Davison, 1986). After a short period, the derived 
catenated genomes are replicated presumable via a rolling-circle mechanism into linear and 
branched concatemeric DNA molecules of serially and covalently linked genomic units 
(Davison, 1984). These high-molecular weight molecules have not been explicitly described 
for VZV, but can be deduced from the generally proposed herpesviral DNA replication 
intermediates and, specifically, from concatemers of herperviruses with similar genome 
arrangements, such as EHV-1 and BoHV-1 (Ben-Porat and Tokazewski, 1977; Boehmer and 
Lehman, 1997; Boehmer and Nimonkar, 2003; Jacob et al., 1979; Schynts et al., 2003; 
Slobedman and Simmons, 1997). 
The concatemeric genome multimers are cleaved precisely at the junctions of the genomic 
termini by a terminase complex and the derived linear unit-length monomers are packed 
through a portal vortex by a head-full sensing mechanism into preformed nucleocapsids 
(Boehmer and Lehman, 1997; Boehmer and Nimonkar, 2003; Davison, 1984). Two highly 
conserved cis-acting DNA packaging signals, termed pac1 and pac2, and an additional pac2-
associated GC-motif that are located near the herpesviral genomic termini, were identified to 
be critical for the DNA maturation and encapsidation process (Deiss et al., 1986; Stow et al., 
1983). In the linear VZV genome, the pac2 signal and its associated GC-motif are situated 
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within the small L repeats and the pac1 element is present within the large S repeats, whereby 
these two packaging signals are found at the opposite genomic termini and next to each other 
at the internal S/L junction (Figure 4) (Davison and Scott, 1986). 
 
Figure 4. Structure of the genomic termini and the internal S/L junction of VZV. A detailed overview of the 
SalI fragments at the genomic termini or at the internal S/L junction of the VZV genome is shown. Herpesvirus-
conserved DNA packaging signals (pac1 and pac2, blue and green) are located at both opposite genomic termini 
and at the internal S/L junction. Additional non-conserved cis-acting DNA packaging signals (red) are assumed 
to be present only at the ORF0 end of the UL region. 
Despite of the very small L repeats, both unique regions of VZV are thought to undergo 
frequent inversion by homologous recombination of the repeat elements during the viral DNA 
replication, creating presumably all four possible genomic isomers directly adjacent and 
tandemly in significant amounts in the concatemeric intermediates (Figure 5) (Davison, 1984; 
Kinchington et al., 1985; Schynts et al., 2003; Slobedman and Simmons, 1997). In regard of 
the genome arrangement of VZV after circularization of the viral DNA, it is assumed that the 
large S repeats promote, at least in part, in addition to the inversion of the US region, also the 
inversion of the UL segment (Davison, 1984). Highly frequent inter- and intramolecular 
homologous recombination seems to be an inherent mechanism of the herpesvirus DNA 
replication machinery, whereby inversions and deletions can be generated by inversely or 
directly repeated elements, which can be even ectopic or extrinsic sequences (McVoy and 
Ramnarain, 2000; Mocarski et al., 1980; Severini et al., 1996; Slobedman et al., 1999; Thiry 
et al., 2005; Umene, 1999). 
 
Figure 5. Rolling-circle mechanism. The displayed model describes VZV DNA replication via the hypothetical 
rolling-circle mechanism. The VZV DNA replicates into concatemeric genome multimers from a “rolling” circu-
lar template intermediate. Both unique regions (US and UL) are thought to undergo frequent inversion during 
DNA replication. The direction of UL and US (small arrows and black to white gradient) and the extent of L and 
S components (dotted lines) including the positions of ORF0 and ORF61 L termini are indicated. 
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Predominantly, two isomers are detectable in equimolar amounts in VZ virion DNA, since the 
US region occurs equally frequent in both orientations, whereas the UL segment is found 
almost in one orientation, only. As a consequence, to 95% the ORF0 and to 5% the ORF61 
end of the UL region is exposed at the L terminus in an encapsidated linear genome (Figure 6) 
(Davison, 1984; Ecker and Hyman, 1982; Straus et al., 1981). This “fixed” orientation of the 
UL region in VZV particle DNA is proposed to be maintained by a selective genome 
packaging process, which is initiated within S/L transitions on concatemeric DNA termini, 
mostly at the ORF0 end (S/L0) and only occasionally at the ORF61 end (S/L61) of the L 
component (Figure 5) (Davison, 1984). Further unconserved cis-acting packaging sequences 
are thought to be uniquely present near the duplicated pac2 and GC-rich signals of the small L 
repeats at the ORF0 end of the UL region and are believed to be the main reason for the 
selective VZV genome packaging into capsids (Figure 4) (McVoy et al., 2000; Wang et al., 
2008). The situation, where two of four possible isomers predominate by inversion of a S 
component relative to a “fixed” L segment in DNA of virions, but where inverted UL regions 
occur frequently in concatemeric DNA, is characteristic for herpesvirus class D genomes, 
which all have large S repeats and only very small, imperfect or even no L-repeats (Schynts et 
al., 2003; Slobedman and Simmons, 1997). In contrast, the herpesvirus class E genome of 
HSV-1, which is organized into two unique regions that are both flanked by large inverted 
repeats, exists equimolarly in all four possible isomers in virion DNA (Hayward et al., 1975; 
Mocarski and Roizman, 1982).  
 
Figure 6. Genome isomers of VZV. Schematic illustration of the four possible isomers of the linear VZV 
genome. In 47.5%, each of the two isomers with ORF0, and in 2.5%, each of the isomers with ORF61 at the L 
terminus is found in VZ virion DNA.  
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3.2 Mutagenesis of herpesvirus genomes 
Herpesvirus genomes range from 100-300 kb and are organized into different unique and 
repetitive regions that contain densely packed, sometimes overlapping ORFs of approximate-
ly 70-220 genes (Davison, 2002; McGeoch et al., 2006; Wang et al., 2007). The intimately 
arranged genes commonly comprise regulatory elements within adjacent coding domains, are 
often encoded via polycistronic transcription units, and in few cases even expressed into 
different splice variants (Davison et al., 2002; Davison and Scott, 1986; Kemble et al., 2000; 
Krause et al., 1988; Roizman et al., 1988; Visalli et al., 2007). Moreover, also microRNAs are 
encoded by herpesvirus DNA (Pfeffer et al., 2005; Pfeffer et al., 2004). In order to maintain 
the integrity of these evolutionarily optimized genomes and to avoid collateral or spurious 
side-effects on the virus viability, minimal and precise sequence modifications are required in 
herpesviral functional investigations. The establishment of such mutagenesis studies has been 
a constant challenging research field for herpesvirologists. 
3.2.1 Progress in herpesvirus genome manipulation strategies 
In the classical approach to analyze herpesvirus genetics, which was introduced almost 40 
years ago, temperature-sensitive mutants with conditionally expressible genes were generated 
by random mutagenesis using chemical compounds (Schaffer, 1975a; Schaffer, 1975b; 
Schaffer et al., 1984). This method was straightforward since it allowed the temperature-
dependent expression of the mutated gene and, therefore, the investigation of even essential 
domains. However, mapping the location of the randomly introduced alteration is time-
consuming and, although the experimental conditions can be well adjusted, second-site muta-
tions are difficult to exclude. Nevertheless, mutants generated by this manipulation strategy 
have in some cases still relevance for herpesvirus investigations, since they enable the 
identification and characterization of virus replication-relevant proteins (Adler et al., 2003; 
Brune et al., 2000; McGregor and Schleiss, 2001; Wagner et al., 2002). 
The progress in molecular biology has provided several innovations to study isolated 
functional genetic domains, but accessing the large herpesvirus genomes directly by standard 
techniques remains limited to the rarely occurring unique endonuclease recognition sites. 
Targeted mutagenesis has been established by introducing a selection marker together with 
the desired genetic alteration into the viral genome via homologous recombination during the 
virus propagation in cultured eukaryotic cells (Manning and Mocarski, 1988; Mocarski et al., 
1980; Post and Roizman, 1981; Smiley, 1980; Spaete and Mocarski, 1987). However, 
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purification of the rarely generated mutant progeny from the over-represented wild-type virus 
can be a laborious procedure and often leads to heterogeneous virus populations. Moreover, 
the investigation of essential genomic regions is logically not feasible with this procedure, 
since the mutant progeny resulting from the rare events of homologous recombination is 
immediately lost in presence of the fully replication-competent wild-type virus (Adler et al., 
2003; Brune et al., 2000; McGregor and Schleiss, 2001; Wagner et al., 2002).  
The disadvantages of the replication-dependent site-directed mutagenesis were considerably 
reduced by cloning large fragments of herpesvirus genomes as sets of overlapping cosmids in 
E. coli (Zijl et al., 1988). The cloned viral DNA can be manipulated precisely by molecular 
biology techniques or bacterial genetics and afterwards transferred as cosmid vector-free 
linear molecules into virus-permissive eukaryotic cells to allow the reconstitution of mutant 
progeny. This procedure involves the possibility to investigate even essential sites of the viral 
genome, since replication-deficient progeny can be identified by providing the deleted essen-
tial sequence on vector vehicles in trans or by trans-complementing cell lines. However, the 
genome repair from the overlapping viral DNA fragments in eukaryotic cells is often associa-
ted with illegitimate events of homologous recombination or unwanted second-site mutations 
(Adler et al., 2003; Brune et al., 2000; McGregor and Schleiss, 2001; Wagner et al., 2002).  
3.2.2 Infectious bacterial artificial chromosomes  
In the past years, the large DNA genomes of numerous herpesviruses, including that of VZV, 
and of some poxviruses as well as some large RNA virus genomes have been constructed as 
infectious bacterial artificial chromosomes (BACs) (Almazan et al., 2006; Almazan et al., 
2000; Borst et al., 1999; Cottingham et al., 2008; Delecluse et al., 1998; Domi and Moss, 
2002; Horsburgh et al., 1999; Messerle et al., 1997; Nagaike et al., 2004; Schumacher et al., 
2000; Smith and Enquist, 2000; Stavropoulos and Strathdee, 1998; Zhou et al., 2002). Full-
length viral DNA can be maintained and manipulated in E. coli and subsequently delivered 
into virus-permissive eukaryotic cells to immediately allow the reconstitution of mutant pro-
geny that will represent a uniform and homogenous virus population. Infectious recombinant 
progeny is, thus, recovered from mutated viral DNA in a controlled manner without the 
requirement for any additional homologous recombination events to restore the genome 
integrity, as it would be the case when the virus is reconstituted from overlapping cosmid 
fragments. The BAC technology has been proven to be a safe, fast, and effective approach to 
get insight into herpesvirus biology and is predicted to facilitate the development of thera-
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peutic gene and vaccine vectors (Adler et al., 2003; Brune et al., 2000; McGregor and 
Schleiss, 2001; Messerle et al., 1997; Wagner et al., 2002). 
BACs are single-copy bacterial F-factor-derived replicon units and have enabled the stable 
cloning of DNA molecules up to 300 kb in recombination-deficient E. coli strains (Shizuya et 
al., 1992). Regulatory elements of the mini-F replicon strictly maintain the BAC in one or 
maximally two copies per bacterial cell, thus, minimizing the potential for inter- and intra-
molecular homologous recombination between repeated or duplicated sequences (Shizuya et 
al., 1992; Shizuya and Kouros-Mehr, 2001). Yeast artificial chromosomes (YACs) can 
propagate larger inserts than BACs, but often appear to have chimeric inserts, sequence 
rearrangements or contaminations with genomic DNA after purification from the host cell 
(Ramsay, 1994; Schalkwyk et al., 1995). Mini-F replicons even confer a higher degree of 
stability to the cloned insert sequences in E. coli than cosmid-based plasmids, which are only 
suitable to maintain DNA fragments up to 50 kb in bacteria (Kim et al., 1992). Therefore 
BACs, or the similarly constructed bacteriophage P1 based replicons (PACs) with comparable 
attributes, have become the vehicles of choice for cloning large and complex genomes in E. 
coli (Ioannou et al., 1994; Shizuya et al., 1992). In addition to the generation of infectious 
viral DNA clones, mini-F replicons are widely used in sequencing projects and functional 
genomics of diverse organisms, and for the construction of targeting and gene therapy vectors 
(Copeland et al., 2001; Ristevski, 2005; Shizuya and Kouros-Mehr, 2001; Sparwasser and 
Eberl, 2007; Yang and Gong, 2005).  
Herpesvirus BACs are usually generated by the insertion of a mini-F vector into a non-
essential genomic region via homologous recombination during the virus propagation in 
eukaryotic cells and subsequent transfer of circular replication intermediates of selected 
recombinant progeny into E. coli (Figure 7) (Messerle et al., 1997). In an alternative strategy, 
the mini-F sequences are inserted via recombination in E. coli into the viral DNA cloned as 
infectious overlapping cosmids, which are afterwards delivered into virus-permissive cells, 
and circular replication intermediates of reconstituted progeny are transferred back into 
bacteria (Figure 7) (Tischer et al., 2007). To generate substantial amounts of recombinant 
circular replication intermediates for the transfer into E. coli and, moreover, to reconstitute 
progeny from the BAC that has attributes comparable to the wild-type virus, the mini-F 
replicon has to be inserted into or instead of a well-defined non-essential genomic region. 
Once the viral genome is established as a single infectious BAC clone in E. coli and virus can 
be reconstituted from the cloned DNA in eukaryotic cells that is virtually indistinguishable 
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from wild-type virus, the door is wide open for mutagenesis studies (Figure 7) (Adler et al., 
2003; Brune et al., 2000; McGregor and Schleiss, 2001; Wagner et al., 2002).  
Although the mini-F sequences were inserted into a genomic region that is dispensible for the 
virus propagation, they can still interfere with specific viral functions especially in further in 
vivo experiments (Adler et al., 2001; Chang and Barry, 2003; Strive et al., 2006; Strive et al., 
2007; Tanaka et al., 2003; Wagner et al., 1999; Zhao et al., 2008). In addition, the current 
localization limits the versatility of an established BAC for specific manipulation procedures 
and minor detrimental effects on the viral replication are not immediately conceivable, which 
can be even more complicated in concern of vaccine and therapeutic vector development. 
Therefore, the bacterial vector elements of herpesvirus BACs are often flanked by loxP or 
FRT sites to enable their excision after virus reconstitution by site-specific recombinases, 
which leave behind only one small residual recognition sequence (Adler et al., 2001; Chang 
and Barry, 2003; Smith and Enquist, 2000; Tanaka et al., 2003; Zhao et al., 2008). Complete 
removal of the mini-F sequences by homologous recombination has been limited to laborious 
co-transfection experiments or to BAC constructs with restricted stability in bacteria (Strive et 
al., 2007; Wagner et al., 1999).  
 
Figure 7. Generation and mutagenesis of herpesvirus BACs. A) Cloning a herpesviral genome as bacterial 
artificial chromosome (BAC). A mini-F plasmid (green) is inserted into the viral DNA via homologous recombi-
nation (crossed lines) during the virus propagation in infected eukaryotic cells. Circular replication intermediates 
are isolated and transferred into E. coli to establish an infectious BAC. Alternatively, the mini-F plasmid is first 
inserted into the viral DNA cloned as overlapping fragments in cosmid vectors (cyan) in E. coli. The overlapping 
fragments are purified and linearized, and subsequently transferred as cosmid vector-free DNA into virus-per-
missive cells. Circular DNA intermediates of recovered virus are then isolated and transformed into E. coli. B) 
Herpesvirus BAC technology. The herpesviral BAC is maintained in E. coli and a mutation is introduced into the 
viral DNA by homologous recombination. The manipulated BAC is isolated and transfected into virus-per-
missive eukaryotic cells, where mutant progeny is reconstituted. 
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3.2.3 Progress in varicella-zoster virus research 
Considerable progress in understanding VZV has been made by the determination of the 
genomic sequences of several wild-type isolates and by the functional analysis using infec-
tious DNA cosmids (Cohen and Seidel, 1993; Davison and Scott, 1986; Mallory et al., 1997). 
Further insights in VZV biology have been gained by the development, usage, and investi-
gation of effective antiviral agents or live-attenuated vaccines that ameliorate or prevent 
varicella and herpes zoster (Oxman and Levin, 2008; Oxman et al., 2005; Pickering, 2008; 
Pickering and Orenstein, 2002; Takahashi et al., 2008; Takahashi et al., 1974; Tan et al., 
1996; Whitley, 1999; Whitley, 2008). However, in contrast to other human herpesviruses, 
there is a huge accumulated demand for VZV investigation because of the impaired handling 
of the virus in cell culture and its replication discrepancies in vivo and in vitro. For example, 
nucleotide polymorphisms of the vaccine strain Oka (V-Oka) in comparison to parental Oka 
(P-Oka) or to other wild-type VZV strains have been intensively characterized and have been 
located predominantly within the transactivator ORF62/71 gene of the large S repeats, but 
which point mutations actually cause the attenuated phenotype of V-Oka is not yet known 
(Gomi et al., 2002; Yamanishi, 2008). Recently, the genome of a vaccine strain has been 
constructed as infectious BAC to facilitate the investigation of the attenuated phenotype of 
VZV (Nagaike et al., 2004; Yoshii et al., 2007). 
Our research group demonstrated that primary wild-type VZV isolates, such as HJO, but not 
the vaccine strain V-Oka, induce sensitivity to adrenergic stimulation of sensory neurons in 
vitro, which corresponds with in vivo observations on neuropathic alterations associated with 
herpes zoster, but the molecular background for this observation remains to be elucidated 
(Kress and Fickenscher, 2001; Schmidt et al., 2003). In addition, the wild-type isolate HJO 
has not been passaged extensively in culture, in contrast to laboratory and Oka strains. The 
VZV strain HJO can therefore be accepted as an ideal candidate to get further insight into the 
neuronal alterations associated with herpes zoster and VZV infection. Therefore, we previous-
ly constructed the genome of the HJO strain as infectious BAC.  
3.3 Manipulation of bacterial artificial chromosomes 
Site-directed manipulation of DNA sequences in E. coli by homologous recombination has 
been established for a number of conditional or transient expressible systems. One of the most 
commonly exploited techniques for the rapid and targeted DNA mutagenesis in bacteria are 
based on Red recombination or RecET cloning (Lee et al., 2001; Murphy, 1998; Muyrers et 
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al., 2004; Muyrers et al., 2000; Yu et al., 2000; Zhang et al., 1998). Recombination-mediated 
genetic engineering (recombineering) relying on Red and RecET manipulation procedures 
have enabled the generation of almost unlimited modifications of large BAC-cloned DNA 
sequences in E. coli and are, thus, widely used methods in functional genomics of diverse 
organisms (Copeland et al., 2001; Muyrers et al., 2001; Sawitzke et al., 2007; Sharan et al., 
2009; Thomason et al., 2007). 
3.3.1 Red recombination-mediated DNA manipulation  
The bacteriophage  recombination system Red consists of the 5‟-3‟-exonuclease Exo and the 
single-strand DNA (ssDNA) binding protein Beta. These two proteins mediate in E. coli the 
recombination between dsDNA ends and homologous target sequences on replicating mole-
cules, and are naturally involved in the integration of the phage  DNA into the bacterial host 
chromosome (Carter and Radding, 1971). Exo acts processively on the dsDNA ends to 
generate 3‟-ssDNA overhangs (Little, 1967). Beta subsequently recognizes the recessed ends 
and invades them by its capability to anneal complementary ssDNA into preformed 
replication forks for their recombination with the homologous sequence (Kmiec and 
Holloman, 1981; Muniyappa and Radding, 1986).  
For efficient DNA manipulation in bacteria, the red genes are expressed together with the  
gam gene under tight control of a temperature-inducible promoter (Murphy, 1998; Yu et al., 
2000). Gam is an inhibitor of the E. coli RecBCD exonuclease, which rapidly degrades 
dsDNA invading into the bacterial host (Karu et al., 1975; Murphy, 1991; Murphy, 2007). 
Expressing the Red recombination system, a linear fragment bearing only 40-50 bp homolo-
gous extensions can be inserted into to a target sequence of interest by the action of Exo and 
Beta, while Gam inhibits the RecBCD enzyme from attacking the dsDNA ends. The Red 
system does not require the support of the E. coli recA protein, which is naturally the main 
mediator for homologous recombination in bacteria (Murphy, 1998; Yu et al., 2000). Thus, 
Red recombination can be used to easily manipulate plasmids or the bacterial host DNA in an 
recombination-deficient background (recA‾) by polymerase chain-reaction (PCR) products 
that were generated with primers comprising short target sequence homologous nucleotides at 
their 5‟-termini (Copeland et al., 2001; Oppenheim et al., 2004; Yu et al., 2000).  
Red-mediated DNA manipulation was adapted for BAC mutagenesis by expressing the red 
genes and gam from a defective prophage integrated into E. coli host genome, which obviates 
the maintenance of an additional expression plasmid (Lee et al., 2001). The  prophage 
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system is 50 to 100-fold more efficient than recombineering by expressing the Red functions 
from a plasmid construct transformed into the E. coli cells (Lee et al., 2001; Yu et al., 2000). 
In addition, the expression of the Red proteins is much more tightly controlled under the 
temperature-inducible promoter in the prophage system than in the plasmid strategy, which 
also reduces the risk of unwanted recombination during the bacterial replication. 
For the selection of E. coli cells harbouring recombinant DNA, the desired mutation is 
inserted into the target sequence of interest together with a resistance gene. To minimize side-
effects on the function of the manipulated region, the selection marker is usually integrated 
into the DNA with flanking loxP or FRT sites to enable its excision from the recombinants in 
bacteria by the expression of the recombinases Cre or FLP (Lee et al., 2001; Yu et al., 2000). 
However, the persistence of at least one copy of the FRT or loxP sites limits the repeatability 
of this procedure and may also interfere with the viral gene expression in some circumstances.  
3.3.2 Two-step en passant mutagenesis  
Recently, a few straightforward recombination systems have been introduced for engineering 
BAC DNA in E. coli without retaining any operational sequences (Sawitzke et al., 2007; 
Sharan et al., 2009; Thomason et al., 2007; Tischer et al., 2009; Tischer et al., 2006; Warming 
et al., 2005). Two-step en passant mutagenesis is a versatile and highly efficient markerless 
BAC manipulation technique, combining Red recombination with the cleavage of the homing 
endonuclease I-SceI (Tischer et al., 2009; Tischer et al., 2006). The non-symmetrical 18 bp I-
SceI recognition site can be introduced into E. coli and cleaved after expression of the homing 
enzyme with a high degree of sequence specificity to generate dsDNA ends accessible for 
homologous recombination (Jamsai et al., 2003). In the en passant procedure, large primers 
are designed to generate a PCR product for the insertion by Red recombination of a selection 
marker together with an I-SceI recognition site flanked by a 50 bp direct sequence duplication 
into the target sequence. After selection of recombinants, a double-strand break can be 
initiated at the I-SceI recognition site to seamlessly excise the positive selection marker by a 
second Red-mediated homologous recombination utilizing the short duplicated sequences. 
Using corresponding available plasmid tools and bacterial strains, en passant mutagenesis can 
be applied to rapidly generate point-mutations, substitutions, or large deletions, to insert large 
sequences or expression cassettes, or to include epitope-tagged or autofluorescent fusion 
proteins (Figure 8) (Tischer et al., 2009; Tischer et al., 2006). 
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To generate point mutations in BAC clones using en passant mutagenesis, a cassette compri-
sing a positive selection marker (psm) and an I-SceI recognition site is PCR-amplified with 
primers adding extensions of 60-80 bp to the psm-I-SceI cassette (Figure 8A). The outer 40-
50 bp of the primers and the derived PCR products are homologous to the target locus in the 
BAC DNA. Both primers are also constructed in such a way that they contain approximately 
40-50 bp of the mutated target sequence, which are reverse complementary to each other 
(Figure 8A). In the first Red recombination, the PCR product containing the positive selection 
marker flanked by the appropriate sequence duplication and modification is inserted into the 
locus of interest. In a second step, following the cleavage induction at the I-SceI site, Red 
recombination between the duplicated sequences results in the excision of the positive selec-
tion marker and the generation of the markerless point mutation (Figure 8A). Large deletions 
are introduced via a similar strategy except that the primers used to amplify the psm-I-SceI 
cassette contain correspondingly arranged 5‟-extensions homologous to the regions up- and 
downstream of the sequence to delete (Figure 8C).  
Large sequences of interest can be seamlessly inserted into a target region by en passant 
mutagenesis via PCR amplification of correspondingly prepared transfer constructs. There-
fore, a construct is cloned that contains the sequence of interest with an inserted positive 
selection marker, an adjoining I-SceI site, and a duplication of a 40-50 bp short stretch of the 
sequence of interest. This construct is generated by PCR amplification of a psm-I-SceI 
cassette with a forward primer containing an approximately 50 bp DNA duplication of 
nucleotides present in the sequences of interest (Figure 8B). In addition, both the forward and 
reverse primers contain restriction sites to allow the cloning of the PCR product in the correct 
orientation into a unique restriction site within the sequences of interest. The unique 
restriction site is chosen in such a way that it is located immediately upstream of the 
approximately 50 bp sequence duplicated within the forward primer (Figure 8B).  
The transfer construct is then used to insert the sequence of interest precisely into the desired 
target region present in the BAC. First, the transfer construct is amplified by PCR with 
primers possessing approximately 50 bp of homology to the respective target (Figure 8B). 
The resulting linear DNA fragment is then inserted into the target BAC clone by Red 
recombination. Recombinants are selected and the resistance marker is seamlessly removed in 
the second en passant step via recombination of the engineered 50 bp duplication of the 
inserted sequence of interest (Figure 8B). 
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Figure 8. The en passant mutagenesis. The shown scheme is adapted from Tischer et al. (Tischer et al., 2006) 
A) Generation of point mutations. First, a positive selection marker (psm) and an I-SceI site are amplified via 
PCR with primers bearing 60-80 bp homologous extensions (coloured elements). Approximately 40-50 bp 
around the target core sequence (red and blue) of both primers are reverse complementary and contain the 
mutation (rectangles). The PCR product is inserted via Red recombination into the target sequence. After 
initiation of a double-strand break at the I-SceI site, psm is excised via Red recombination of the duplication, 
leaving behind only the point mutation. B) Insertion of large sequences. First, a psm-I-SceI cassette is amplified 
with primers, of which one provides a 40-50 bp duplication (yellow), and inserted into a restriction site 
(asterisks*) of a cloned sequence of interest (soi). Subsequently, the soi transfer construct is PCR-amplified with 
primers comprising 40-50 bp extensions (red and blue), and inserted into the target region via Red recom-
bination. Upon expression of I-sceI and red, psm is excised from soi by recombination of the short duplication. 
C) Generation of large deletion. A psm-I-SceI element is amplified with primers, each having 5‟-ends that are 
homologous to sequences located adjacent to the region to delete (coloured elements). The resulting product is 
used to delete the region of interest by Red recombination. The following steps are the same as in A.  
3.4 Objectives of the thesis 
A long-term objective of our group is the definition of the sequence variations responsible for 
the attenuated vaccine phenotype and for the pain induction during herpes zoster and VZV 
infection. In order to facilitate these approaches, we previously constructed the genomes of 
the VZV strains parental Oka (P-Oka) and HJO as infectious BACs in E. coli to rapidly 
generate appropriate VZV mutants for functional investigations.  
During this thesis project, the two established VZV BACs should be modified by the highly 
versatile and markerless en passant mutagenesis, to provide the efficient and seamless exci-
sion of the bacterial vector sequences after virus reconstitution. The engineered BAC variants 
should allow on one hand the stable propagation of the cloned VZV genomes in Red-recom-
bination-competent E. coli and on the other hand the rapid release of the vector elements 
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during viral DNA replication in eukaryotic cells. Such infectious BAC clones would facilitate 
the generation of recombinant VZV with seamlessly manipulated viral DNA and, thus, allow 
the precise interpretation of the derived mutant phenotype. 
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4. Results 
4.1 The BAC-cloned infectious genomes of VZV strains P-Oka and HJO  
The infectious BACs of the full-length VZV genomes P-Oka and HJO, termed pP-Oka and 
pHJO, were previously generated via cosmid vector-based strategies by Tischer et al. and 
Schmidt et al. (Figure 7) (Schmidt and Fickenscher, 2009; Tischer et al., 2007). For the 
construction of pP-Oka, a shortened derivative of the pBeloBAC11 vector, comprising the 
essential mini-F replicon elements oriS, repE, sopA, sopB and sopC, and the chloramphenicol 
(Cm) resistance gene cat as a positive selection marker, but not the loxP and cos sequences, 
was placed directly between the poly-A signals of ORF64 and ORF65 of the P-Oka VZV 
genome (Figure 9). This mini-F vector insertion position is located within the IRS region of 
the large S repeats approximately 200 bp distant to the UL region. The pHJO BAC construct 
was generated via the insertion of the complete pBeloBAC11 sequences into the unique AvrII 
site of the US region between the ORF65 and ORF66 of the VZV HJO genome (Figure 9). 
With respect to the defined VZV prototype genome organization (Figure 2 and 4), the unique 
regions of pHJO are inversely oriented to each other in the circular BAC arrangement.  
 
Figure 9. The infectious BACs pP-Oka and pHJO. For the generation of pP-Oka, a shortened derivate of 
pBeloBAC11 sequences without loxP and cos sequences, was placed between the poly-A signals of ORF64 and 
ORF65 of the IRS region of the P-Oka VZV genome. To establish pHJO, the mini-F sequences were inserted 
into the unique AvrII site of the VZV US region between the ORF65 and ORF66 of the HJO genome.  
The circular VZV genomes of the BACs with directly or reversely oriented unique regions 
can be the result of one of the major and one of the minor linear isomers (Figure 6). There-
fore, it is only possible to determine the terminal and internal genomic junction as well as the 
terminal and internal repeats with a probability of 95%. Despite of this complication, the 
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repeated elements of the circular VZV genomes are usually defined according to their 
designation in the two predominantly occurring genomic isomers (Kemble et al., 2000; 
Nagaike et al., 2004; Tischer et al., 2007; Yoshii et al., 2007). The three duplicated ORFs 
within the large S repeats are commonly defined according to their relative position to the 
orientation of the US region of the VZV prototype isomer (Figures 2 and 4). Consequently, 
the ORF62, ORF63, and ORF64 are located within pP-Oka in the IRS region and are repeated 
as ORF71, ORF70, and ORF69 in the TRS region, whereas vice versa in pHJO (Figure 9). 
Both pP-Oka and pHJO could be stably propagated in E. coli, and allowed upon delivery into 
VZV-permissive eukaryotic cells the reconstitution of recombinant progeny that exhibited 
replication kinetics comparable to that of the wild-type viruses P-Oka or HJO (Schmidt and 
Fickenscher, 2009; Tischer et al., 2007). In addition, the two BACs have been successfully 
used to manipulate the viral genomes via Red recombination in bacteria and to recover and 
characterize mutant virus progeny in vitro (Schmidt and Fickenscher, 2009; Tischer et al., 
2007). Thus, pP-Oka and pHJO are two valuable tools to rapidly generate mutant virus 
progeny for functional investigations. However, to prevent any side-effects of the bacterial 
vector elements with virus functions or adjacent viral sequences, especially in regard of 
further in vivo experiments, I should optimize the two infectious BACs for the efficient and 
seamless self-excision of the mini-F sequences from the VZV genomes upon virus reconsti-
tution in eukaryotic cells. In addition to the recently introduced markerless DNA manipulation 
techniques in E. coli, such BACs would enable the rapid generation of mutant virus without 
any secondary genome alterations or operational sequences.  
4.2 Mini-F vector self-excision by stabilized genomic duplication 
Seamless excision of the mini-F sequences from the viral DNA by homologous recombination 
after virus reconstitution from an infectious herpesvirus BAC has been first introduced by 
flanking the bacterial vector elements with directly oriented 0.5 kb genomic duplications 
(Wagner et al., 1999). Since only one recombination event of such an arranged duplication 
leads to the complete deletion of the mini-F vector from the viral genome, this BAC construct 
has restricted stability during the F-factor mediated replication also in E. coli cells which 
harbour an expression cassette for the recombineering proteins on a defective prophage 
integrated into the host chromosome. We assumed that the vector elements can also be 
released from the viral DNA in eukaryotic cells and additionally stabilized within the cloned 
genome in E. coli when a genomic duplication of viral sequences flanking the mini-F 
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insertion site is introduced in forward or even in reverse direction between the bacterial origin 
of replication and the resistance gene of the BAC vector (Figure 10).  
If such a genomic duplication was introduced in forward orientation into the vector sequences 
of the viral BAC, any single recombination should separate the mini-F replicon from the resis-
tance gene (Figure 10A). Therefore, we supposed that the growth of bacteria harbouring such 
deletion constructs can be prevented by steady selection with antibiotics, since both the mini-
F replicon and the resistance gene are then required for the survival of the E. coli cells. In 
addition, if a corresponding genomic duplication was inserted in inverse orientation between 
the replicon unit and the selection marker, an antiparallel recombination event followed by a 
successive parallel recombination should be necessary for the complete excision of the bacte-
rial vector elements from the viral DNA (Figure 10B). However, we assumed that such a suc-
cessively induced recombination reaction is unlikely in E. coli regarding the reduced potential 
for homologous recombination during the strictly controlled F-factor-mediated replication 
(Shizuya et al., 1992; Shizuya and Kouros-Mehr, 2001). Taken together, we concluded that a 
herpesvirus BAC with forward or reverse genomic duplication, regardless of whether it 
contains inversely or directly repeated regions of the cloned viral DNA, inserted between the 
replicon unit and the resistance gene, should be stabilized in E. coli by the reduced potential 
of homologous recombination provided by the low-copy mini-F replicon and additionally by 
antibiotic selection. 
 
Figure 10. Self-excision of BAC sequences by stabilized genomic duplication. A) BAC vector (green) self-
excision from the viral DNA (black) by a forward genomic duplication (yellow to red gradient bars) inserted 
between the mini-F replicon (mFr) and the antibiotic resistance gene (arg). Two independent recombination 
events are necessary to release the mini-F replicon or the resistance gene from the viral DNA. B) Self-excision of 
the BAC sequences from the viral DNA by a genomic duplication inserted in inverse orientation into the vector 
elements. Here, two successive events of recombination are required for the complete excision of the BAC 
sequences from the viral DNA.  
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In contrast to the propagation in E. coli, parallel and antiparallel inter- and intramolecular 
homologous recombination is frequently mediated during the herpesviral DNA replication 
and a maintenance mechanism for the bacterial vector elements is not active in eukaryotic 
cells (McVoy and Ramnarain, 2000; Mocarski et al., 1980; Severini et al., 1996; Slobedman 
et al., 1999; Thiry et al., 2005; Umene, 1999). For this reason, we assumed that a genomic 
duplication inserted into the vector elements of a herpesviral BAC, independently of its orien-
tation, can rapidly induce the seamless self-excision of the complete vector sequences upon 
virus reconstitution in permissive cells. In the first task of my thesis, I planned to engineer 
corresponding genomic duplications between the oriS origin of replication and the cat gene or 
the pBeloBAC11 sequences of the two established VZV BACs pP-Oka and pHJO. To evalu-
ate which arrangement can mediate more efficiently the mini-F sequence self-excision after 
virus reconstitution, the duplication should be introduced into the vector elements in reverse 
as well as in forward orientation. 
4.2.1 Insertion of genomic duplications into the BAC vector sequences  
For the insertion of the forward and reverse genomic duplications into the pBeloBAC11 
sequences of pP-Oka and pHJO, I used the plasmids pEP-P-Oka-DXfw-in, pEP-P-Oka-DX-
in, pEP-HJO-DXfw-in, and pEP-HJO-DX-in (Figure 11). These plasmids were provided by 
Dr. Tischer and derived from the universal transfer vector pEPMCS-in-Belo (Figure 11), 
which is ready for en passant mutagenesis. The transfer construct of pEPMCS-in-Belo 
consists of the kanamycin resistance gene aphAI, an I-SceI homing endonuclease restriction 
site, a short 50 bp directly oriented duplication of pBeloBAC11 sequences that flank the 
aphAI-I-SceI fragment, a multiple cloning site (MCS), and 0.7 kb pBeloBAC11 sequences 
flanking the entire aphAI-I-SceI-MCS cassette and homologous to regions of the oriS of the 
mini-F replicon or to the cat gene (Figure 11). To release the transfer construct from the 
vector backbone, it was placed between the two I-CeuI sites of the plasmid pCeu2 (Figure 11) 
(Tischer et al., 2007). The pCeu2 plasmid contains a MCS between two 19 bp I-CeuI homing 
endonuclease recognition sites and, thus, allows the cloning and subsequent release of very 
large sequences from the vector backbone without taking the risk to cleave the inserted DNA. 
Consequently, pEPMCS-in-Belo can be easily applied to insert large sequences via the MCS 
of the transfer construct into the pBeloBAC11 elements between the oriS and the cat gene and 
to seamlessly release the aphAI selection marker afterwards by two-step Red-mediated en 
passant mutagenesis. For the construction of the provided plasmids pEP-P-Oka-DXfw-in and 
pEP-P-Oka-DX-in, a 1.6 kb P-Oka genomic region of 0.5 kb and 1.1 kb sequences adjoining 
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the poly-A signals of ORF64 and ORF65 were PCR amplified with the primers A and B 
(Table 1), afterwards digested with SpeI and inserted in forward or reverse direction into the 
AvrII site between the Belo fragments of the universal transfer construct of pEPMCS-in-Belo 
(Figure 11). To construct pEP-HJO-DX-in and pEP-HJO-DXfw-in, 1.4 kb HJO wild-type 
sequences of 0.7 kb regions that are located adjacent to the unique AvrII site of the VZV US 
region were amplified by PCR with the primers C and D (Table 1) and cloned analogously 
into the MCS of the pEPMCS-in-Belo transfer construct (Figure 11).  
 
Figure 11. Generation of the plasmids pEP-P-Oka-DXfw-in, pEP-P-Oka-DX-in, pEP-HJO-DXfw-in, and 
pEP-HJO-DX-in. To generate the plasmids, 1.6 kb P-Oka or 1.4 kb HJO wild-type sequences found at either 
sites of the poly-A signals of ORF64 and ORF65, or the unique AvrII site of the VZV US region, were intro-
duced in forward or inverse orientation into the MCS of the universal transfer construct of plasmid pEPMCS-in-
Belo. The transfer construct consists of an aphAI-I-SceI cassette (cyan), a 50 bp pBeloBAC11 duplication (small 
green arrows), a multiple cloning site (MCS) and 0.7 kb pBeloBAC11 elements (green). The whole construct 
was placed in the MCS between the two I-CeuI sites of the vector pCeu2. 
Using the transfer constructs, the corresponding duplications of P-Oka and HJO were inserted 
by en passant mutagenesis in E. coli GS1783 into the pBeloBAC11 vector of the BACs pP-
Oka and pHJO. E. coli GS1783 cells were used for the en passant manipulation procedure 
because they harbour an expression cassette integrated into the host chromosome for the 
homing endonuclease I-SceI and the Red recombination proteins (Tischer et al., 2009). With 
this bacteria strain, introduction and temporary maintenance of an additional plasmid for I-
sceI expression in E. coli was not necessary during the en passant procedure. Since the 
plasmid pEP-P-Oka-DXfw-in contained a double-insert of the viral sequences within the 
MCS, a duplication was not inserted additionally in forward orientation into the pBeloBAC11 
vector of pP-Oka. In the first step of the en passant mutagenesis, the transfer constructs of 
pEP-P-Oka-DX-in, pEP-HJO-DX-in, and pEP-HJO-DXfw-in were released from the plasmid 
backbone by I-CeuI digestion and used to introduce via Red recombination the 1.6 kb or 1.4 
Results 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
27 
kb viral sequence duplications together with the aphAI-I-SceI cassette flanked by the direct 50 
bp pBeloBAC11 duplication in inverse or forward orientation between the oriS and the cat 
gene of pP-Oka or pHJO (Figure 12A). After selection of recombinants, the aphAI resistance 
gene was seamlessly excised from the vector backbone of the BACs in the second en passant 
step by I-SceI double-strand break-promoted and Red-mediated homologous recombination of 
the 50 bp pBeloBAC11 duplication (Figure 12A).  
 
Figure 12. Construction of pP-Oka-DX, pHJO-DXfw, and pHJO-DX. A) Generation of pP-Oka-DX. The 
transfer construct EP-P-Oka-DX-in was used to insert 1.6 kb P-Oka sequences adjoining the mini-F insertion site 
(yellow to red gradient bars) between the oriS and the cat gene of the pBeloBAC11 vector (green) of pP-Oka and 
to remove afterwards the selection marker aphAI (cyan) by two-step en passant Red recombination (green lines), 
resulting in pP-Oka-DX. Upon virus reconstitution, the mini-F sequences were released by two events of homo-
logous recombination (yellow to red dotted lines). Primers P1 and P2 were used to analyze the vector excision 
and primers P3 and P4 or P5 and P6 were used to determine the persistence of sopA and cat sequences B) Con-
struction of pHJO-DXfw and pHJO-DX. In this constructs, 1.4 kb genomic duplication (yellow to red gradient 
bars) were engineered in forward or reverse orientation within the pBeloBAC11 elements of pHJO. Primers P7 
and P8 were used to investigate the excision of the vector elements by homologous recombination (yellow to red 
dotted lines) upon virus reconstitution from the two pHJO-DX clones. 
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The resulting self-excisable BACs with reversely (DX) or forwardly (DXfw) inserted duplica-
tion in the pBeloBAC11 sequences were termed pP-Oka-DX and pHJO-DX, or pHJO-DXfw, 
respectively (Figure 12). These BACs allowed the stable propagation of the P-Oka or HJO 
genome in E. coli grown in presence of Cm and the seamless excision of the pBeloBAC11 
elements from the viral DNA by two events of homologous recombination after virus recon-
stitution in VZV-permissive eukaryotic cells (Figure 12). 
4.2.2 Maintenance of the BAC-cloned VZV DNA after insertion of genomic duplications 
To verify the maintenance of the BAC-cloned HJO genome and the insertion of the genomic 
duplications, I prepared the original pHJO BAC and both pHJO-DX constructs from E. coli 
GS1783 cells, digested the BAC DNAs with XhoI, SacI, or SwaI and compared the resulting 
restriction fragment length polymorphism (RFLP) pattern. The observed fragment 
rearrangements of pHJO-DXfw and pHJO-DX in relation to the original pHJO BAC were 
confirmed to correspond to the insertion of the forward or reverse genomic duplication into 
the pBeloBAC11 elements (Figure 13). For example, the 7.6 kb SacI fragment of pHJO which 
comprises the vector sequences appeared in pHJO-DXfw and pHJO-DX due to the presence 
of the 1.4 kb genomic duplications within the vector as a 9 kb SacI fragment (Figure 13).  
 
Figure 13. RFLP analysis of pHJO-DXfw and pHJO-DX. B) RFLP analysis of XhoI, SacI, or SwaI digested 
pHJO-DXfw of pHJO-DX BAC DNA in comparison to original pHJO. DNA fragments containing the 
pBeloBAC11 vector sequences (green arrows) or sequences of the genomic duplications (blue arrows) are 
marked. All fragment rearrangements of the engineered BACs correspond to the insertion of the genomic 
duplication into the vector elements. 
Results 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
29 
The restriction fragment patterns of pP-Oka-DX were investigated via Southern-blot 
hybridization (see section 4.2.4) and the detected fragment shifts in comparison to the original 
pP-Oka-DX clone correlated also with the expected fragments sizes according to the insertion 
of the reverse genomic duplication into the pBeloBAC11 vector sequences. In addition, the 
presence of the corresponding reverse or forward genomic duplications in the pP-Oka-DX and 
pHJO-DX or pHJO-DXfw BAC DNA was confirmed via PCR (data not shown). Since 
unexpected rearrangements were not detected in the derived restriction fragment patterns, 
these results demonstrated that the three engineered VZV BAC can be stably propagated by 
the mini-F replicon in Red-recombination-proficient E. coli cells, independently in which 
direction the duplicated sequences were introduced into the pBeloBAC11 vector elements. 
4.2.3 Genome position-dependent BAC vector self-excision by genomic duplication 
For the investigation of the mini-F vector excision after virus reconstitution from pP-Oka-DX, 
pHJO-DXfw, or pHJO-DX, I purified the BAC DNAs from E. coli and transfected them into 
the eukaryotic VZV-permissive melanoma cell line MeWo. In contrast to primary cells that 
promote the propagation of VZV in vitro, such as human forskin fibroblast (HFF), MeWo 
cells are highly receptive for DNA by transfection (Cohen and Seidel, 1993). In addition, the 
unlimited and dense growth of the MeWo cells allows the viral progeny to pass a high number 
of replication cycles in each virus passage and, thus, the efficient propagation of VZV in cell 
culture. However, as with all other cell lines permissive for VZV, MeWo cells do not release 
substantial amounts of cell-free intact infectious virus particle into the supernatant (Cohen et 
al., 2007; Harson and Grose, 1995). For this reason, whole cell-lysates are usually prepared 
for the investigation of VZV in vitro. 
Virus reconstitution from the three BACs transfected into the MeWo cells was detected by the 
formation of the local, VZV-typical cytopathic effects (CPEs) four to five days post trans-
fection, which corresponded to the time period required for the virus reconstitution from the 
original BACs pP-Oka and pHJO. In consequence of the highly cell-associated growth of 
VZV, the derived recombinant progenies were propagated by the co-cultivation of infected 
cells with uninfected cells. To eventually analyze the elimination of the mini-F sequences by 
the two proposed homologous recombination events of the genomic duplications (Figure 12), 
the DNA of the MeWo cells infected with the recombinant progenies of the different virus 
passages was prepared for PCR analysis. For the determination of the complete excision of 
the pBeloBAC11 elements from the viral DNA in pP-Oka-DX-derived virus or in the 
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progenies generated from the two pHJO-DX clones, I utilized the primers P1 and P2 or P7 
and P8 (Table 1) that annealed within the viral DNA flanking the mini-F insertion site and 
outside of the respective duplicated sequences (Figure 12). To analyze the persistence of the 
two pBeloBAC11 vector fragments separated by the genomic duplication, I applied the 
primers P3 and P4 or P5 and P6 (Table 1) in the PCR, which are specific for the sopA mini-F 
replicon element or the cat gene (Figure 12). In all three recombinant viruses, the removal of 
the mini-F sequences was immediately detectable in a portion of the viral genomes after virus 
reconstitution and not in the corresponding BAC DNA used for the transfection of the MeWo 
cells (Figure 14). In addition, the genomic wild-type sequence was restored between the poly-
A signals at ORF64 to ORF65 in pP-Oka-DX-derived virus and at the unique AvrII site of the 
US region in the two pHJO-DX-derived viruses (data not shown).  
 
Figure 14. PCR anaylsis of the mini-F vector excision upon virus reconstitution from pP-Oka-DX, pHJO-
DXfw, or pHJO-DX. A) PCR analysis of the pBeloBAC11 excision (F) or the persistence of sopA or cat 
sequences in DNA of MeWo cells infected with pP-Oka-DX-, pHJO-DX-, or pHJO-DXfw-derived progeny of 
virus passages 1-5 or 1-8 using the indicated primers (P). BAC DNA as well as DNA of wild-type P-Oka or HJO 
infected cells or uninfected cells were analyzed for control. 
In the pP-Oka-DX- and pHJO-DX-derived progeny, the sopA sequences were detectable only 
until virus passage 4. In contrast, the sopA element was traceable in progeny reconstituted 
from pP-HJO-DXfw until virus passage 8 and beyond (Figure 14). Remaining sequences of 
the cat gene were confirmed to be present in progeny recovered from pP-Oka-DX also until 
virus passage 4, only. However, in both pP-HJO-DX- and pP-Oka-DXfw-derived viruses, the 
cat gene was detected at least until virus passage 8 (Figure 14). Thus, the pBeloBAC11 
Results 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
31 
sequences were efficiently and seamlessly released by the reverse genomic duplication upon 
virus reconstitution from pP-Oka-DX during four rounds of passaging the generated viral 
progeny. In the virus progenies generated from the two pHJO-DX variants, the pBeloBAC11 
sequences were also seamlessly released, but only the sopA vector part was efficiently re-
moved when the genomic duplication was present in inverse orientation within the vector.  
4.2.4 Repair of the VZV genome upon duplication-mediated BAC excision 
Since the mini-F vector self-excision in pP-Oka-DX-derived virus was highly efficient, I in-
vestigated the DNA of the viral progeny devoid of the two vector parts, termed rP-Oka-F‾, via 
Southern-blot, to confirm the correct repair of the P-Oka genome organization. Therefore, I 
prepared total DNA from MeWo cells infected with HJO wild-type virus or rP-Oka-F‾ as well 
as BAC DNA of original pP-Oka or pP-Oka-DX from E. coli GS1783, digested the DNAs 
with BamHI, NcoI, or SphI, and analyzed the resulting restriction fragment patterns by a 
Southern-blot probe specific for pP-Oka fragments or for the pBeloBAC11 vector (Figure 15). 
 
Figure 15. Southern-blot analysis of pP-Oka-DX-derived rP-Oka-F‾. Southern-blot analysis for detection of 
pP-Oka or pBeloBAC11 vector-specific fragments in BamHI, NcoI, or SphI digested DNA from MeWo cells 
infected with wild-type P-Oka or recombinant rP-Oka-F‾, or in BAC DNA of original pP-Oka and engineered 
pP-Oka-DX. Fragments containing sequences of the pBeloBAC11 vector (green arrows) or of the reverse geno-
mic duplication (blue arrows) are marked.  
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The obtained genomic restriction fragment patterns of rP-Oka-F‾ were comparable to that of 
wild-type P-Oka DNA (Figure 15). In addition, pBeloBAC11 sequences were only detected in 
the RFLP pattern of pP-Oka and pP-Oka-DX and not in that of the virus DNA (Figure 15). 
These results demonstrated that the reverse genomic duplication, although it contained 
sequences of the large S repeats (Figure 12A), mediated the required homologous 
recombination events for the repair of the P-Oka genome upon virus reconstitution from pP-
Oka-DX. Thus, pP-Oka-DX allowed the reconstitution of virus progeny that exhibited 
genome properties virtually identical to the wild-type virus P-Oka.  
4.2.5 Extension of the genomic duplications within the BAC vector sequences 
In order to increase the efficacy of the elimination of the cat gene vector part from the unique 
AvrII site, I engineered larger genomic duplications within the pBeloBAC11 sequences of 
pHJO. Therefore, 3 kb viral sequences of 1.5 kb regions that span the unique AvrII site of the 
VZV US region of HJO were amplified with primers E and F (Table 1) and inserted after SpeI 
digestion in forward or reverse direction into the MCS AvrII site between the I-CeuI sites of 
the universal transfer vector pBeloMCS-in-Belo (Figure 11), resulting in pEP-HJO-DX3fw-in 
or pEP-HJO-DX3-in. As described before (Figure 12), the I-CeuI fragments of the generated 
transfer vectors were released and used to insert the viral sequences via en passant 
mutagenesis in E. coli GS1783 cells between the mini-F replicon and the cat resistance gene 
of pHJO. The obtained BAC derivates of pHJO with inverse of forward oriented 3 kb 
genomic duplications within the pBeloBAC11 sequences were termed pHJO-DX3 and pHJO-
DX3fw (Figure 16).  
 
Figure 16. Construction of pHJO-DX3fw and pHJO-DX3. For the construction of pHJO-DX3fw and pHJO-
DX3, 3 kb genomic duplication of 1.5 kb viral sequences (yellow to red gradient bars) flanking the mini-F 
insertion site were engineered within the pBeloBAC11 vector elements (green) of pHJO. 
 
 
Results 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
33 
4.2.6 Stable propagation of the VZV BAC after extension of the genomic duplications 
To confirm the full preservation of the HJO genome after insertion of the 3 kb genomic dupli-
cation into the vector elements, I prepared pHJO-DX3fw and pHJO-DX and original pHJO 
from the GS1783 E. coli cells and compared the XhoI, SacI, and SwaI RFLP pattern of the 
isolated BACs. In relation to the pHJO BAC, only the expected fragment rearrangements that 
correspond with the presence of the 3 kb forward or inverse genomic duplication within the 
pBeloBAC11 vector were detected in the two engineered BACs (Figure 17). For instance, the 
5.6 kb XhoI fragment of pHJO which comprises sequences from the oriS to the cat gene of 
the pBeloBAC11 vector is found in the pHJO-DX3fw and pHJO-DX restriction fragment 
pattern as an 8.8 kb XhoI fragment due to the insertion of the 3 kb genomic duplications 
(Figure 17). The presence of the corresponding forward or reverse genomic duplication 
between the mini-F replicon and the cat gene was also verified via PCR (data not shown). 
These results indicated that even the insertion of the 3 kb genomic duplication into the vector 
elements of pHJO did not have a destabilizing effect on the genome organization during the 
mini-F replication in Red-recombination-competent E. coli cells. 
 
Figure 17. Restriction fragment pattern of pHJO-DX3 and pHJODX3fw. RFLP analysis of XhoI, SacI or 
SwaI digested BAC DNA of the two pHJO-DX constructs in comparison to original pHJO. DNA fragments con-
taining vector elements (green arrows) or sequences of the 3 kb genomic duplication (cyan arrow) are marked.  
4.2.7 Duplication-mediated BAC vector excision depends heavily on genome position 
In order to investigate the excision of the cat gene fragment by homologous recombination of 
the introduced 3 kb genomic duplications during the viral DNA replication, I transfected 
pHJO-DX3fw and pHJO-DX3 BAC DNA into VZV-permissive MeWo cells. Virus recovery 
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by observation of the VZV-typical CPEs was detected in the cell cultures after four to five 
days post transfection. The derived recombinant progenies were propagated as described 
before and cell lysates of the different virus passages were analyzed by PCR using the cat 
specific primers P5 and P6 (Figure 12). In both pHJO-DX3fw- and pHJO-DX3-derived 
viruses, the cat sequences were still detectable until passage 8 and beyond that (Figure 18). 
Thus, even 3 kb genomic duplications within the vector elements did not significantly 
increase the efficacy of the vector elimination from the unique AvrII site of the VZV US 
region upon virus reconstitution from the pHJO-cloned VZV genome. These results 
demonstrated that the efficiency of the novel duplication-mediated self-excision strategy 
apparently depends heavily on the BAC vector insertion site within the viral genome. 
 
Figure 18. PCR anaylsis of the persistence the vector elements in pHJO-DXfw-, or pHJO-DX-derived 
virus progeny. PCR analysis of the persistence of cat sequences in DNA of MeWo cells infected with pHJO-
DXfw-, or pHJO-DX-derived progeny of virus passages 1-8 using the indicated primers (P). BAC DNA as well 
as DNA of wild-type P-Oka or HJO infected cells or uninfected cells were analyzed for control.  
4.3 Duplication-mediated mini-F vector self-excision from essential genes 
Since the duplication-mediated vector release from the unique AvrII site of the US region 
appeared to be significantly impaired, different BAC constructs of the HJO genome were 
required that allow the efficient excision of the mini-F sequences after virus reconstitution. 
We assumed that the elimination of the vector sequences can be significantly increased due to 
a highly detrimental effect on the virus propagation, if they are engineered with corresponding 
genomic duplications in ORFs which are essential for the efficient growth of VZV. However, 
to maintain a potential for homologous recombination of the genomic duplication and, thus, 
the repair of the gene function, the self-excisable vector elements had to be generated in ORFs 
that are not involved in the viral DNA replication.  
The HSV-1 homologs of the VZV ORF22 large tegument protein and of the ORF54 capsid 
portal protein were known to be essential for proper particle assembly or DNA packaging into 
capsids (Batterson et al., 1983; Desai, 2000; Knipe et al., 1981; Lamberti and Weller, 1996; 
Newcomb et al., 2001; Patel et al., 1996). Furthermore, the HSV-1 homolog of the VZV 
ORF50 membrane glycoprotein M had been determined to be dispensible for the virus propa-
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gation, but appeared to be required for the efficient cell-to-cell spread of the viral particles in 
vitro (Baines and Roizman, 1993; Browne et al., 2004; MacLean et al., 1993). In addition, the 
glycoprotein M of the avian -herpesvirus Marek‟s disease virus, which replicates similarly 
to VZV in a highly cell-associated nature in vitro as well as in vivo, was even known to be 
essential for the virus cell-to-cell spread in cell culture (Tischer et al., 2002). Therefore, we 
assumed that the large tegument protein, the glycoprotein M, and the capsid portal protein are 
essential for the VZV propagation in vitro, whereas not involved in the viral DNA replication. 
Consequently, I planned to engineer BAC variants of HJO that encompass self-excisable 
mini-F sequences with corresponding genomic duplications in ORF22, ORF50, and ORF54, 
to induce the rapid pBeloBAC11 excision upon recovery of progeny in eukaryotic cells. To 
ensure the complete disruption of the gene function and, thus, the efficient vector release, the 
pBeloBAC11 elements should be placed into 5‟-end positions of the chosen ORFs. Since a 
genomic duplication in reverse orientation apparently mediates the vector excision during the 
viral DNA replication more efficiently than in forward orientation (Figure 14), the viral se-
quences should be inserted only in inverse direction into the vector sequences of the engi-
neered BAC constructs. 
The only possibility for the targeted generation of HJO BACs with mini-F sequences in essen-
tial viral genes was given by shifting the pBeloBAC11 sequences of pHJO within the cloned 
VZV genome into these positions via homologous recombination in E. coli. For this mini-F 
transposition, a second pBeloBAC11 vector hat to be inserted into the considered essential 
gene, while removing the pre-existing mini-F replicon from the unique AvrII site of the US 
region of the BAC-cloned HJO DNA. However, to prevent the uneven segregation or 
disruption of putative intermediates with two mini-F replicons during the stringently 
coordinated chromosomal-like separation upon bacterial cell division and, thus, the loss of 
BAC or viral sequences, the mini-F vector insertion and removal reaction had be performed in 
an immediately successive reaction (Shizuya et al., 1992; Shizuya and Kouros-Mehr, 2001). 
In addition, the second pBeloBAC11 elements should be inserted in inverse orientation with 
respect to the pre-existing vector fragment to avoid the degradation of the BAC DNA by 
intramolecular homologous recombination. Therefore, we developed a novel mini-F sequence 
transposition protocol, which allows the targeted insertion of the novel pBeloBAC11 vector 
into a different position of the viral genome by Red recombination, simultaneously with the 
seamless removal of the primary mini-F vector from the unique AvrII site of the US region 
via en passant mutagenesis. 
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4.3.1 Red-mediated mini-F vector transposition into VZV essential genes  
For the insertion of the pBeloBAC11 sequences into the 5„-end positions of ORF22, ORF50, 
or ORF54 via Red recombination, I generated the plasmids pBelo-HJO22-in, pBelo-HJO50-
in, and pBelo-HJO54-in as follows. First, to allow the eventual cloning of the mini-F 
sequences into SphI or BamHI sites and to remove redundant sequences, such as the loxP site 
and the cos element, the commercially available pBeloBAC11 vector was digested with SalI 
and the derived 6.4 kb fragment was ligated with the XhoI-treated hybrid of the oligo-
nucleotides G and H or I and J (Table 1), resulting in the BAC vectors pBeloBamHI or 
pBeloSphI, respectively. Subsequently, 1.4 kb viral sequences of 0.7 kb regions flanking 5‟-
end positioned SphI or BamHI sites of ORF22, ORF50, or ORF54, were PCR amplified with 
the primers K and L, M and N, or O and P (Table 1), cleaved with SpeI, and cloned into the 
XbaI site of the MCS of the pCeu2 plasmid. Then, the mini-F plasmid pBeloSphI was cleaved 
with SphI and inserted into the SphI site of the pCeu2-cloned fragment of ORF22 or ORF54 
to generate pBelo-HJO22-in or pBelo-HJO54-in. In an analogous reaction, the BAC vector 
pBeloBamHI was digested with BamHI and inserted in forward orientation into the BamHI 
site of the pCeu2-cloned ORF50 fragment, resulting in pBelo-HJO50-in (Figure 19). 
 
Figure 19. Mini-F vector transfer plasmids pBelo-HJO22-in, pBelo-HJO50-in, and pBelo-HJO54-in. For 
the construction of pBelo-HJO22-in, pBelo-HJO50-in, and pBelo-HJO54-in, the pBeloBAC11 sequences were 
inserted in the SphI or BamHI sites of the pCeu2-cloned fragments of ORF22, ORF50, or ORF54. 
In the first step of the en passant mutagenesis, the original pHJO BAC clone was prepared for 
the subsequent synchronous insertion and excision reaction of the pBeloBAC11 elements. 
Therefore, the kanamycin resistance gene aphAI and the I-SceI recognition site of the plasmid 
pEPkan-S (Tischer et al., 2006) were amplified by PCR with the primers Q and R (Table 1), 
whereby the latter provided a 50 bp duplication of viral sequences found adjacent at the left 
vector end of pHJO, and used to substitute the cat gene at the right pBeloBAC11 vector termi-
nus in pHJO via Red recombination in E. coli GS1783 (Figure 20). The resulting BAC con-
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struct, termed pHJOFep, with aphAI-I-SceI linked pBeloBAC11 mini-F replicon flanked by a 
50 bp genomic sequence duplication was ready for the integration of the second pBeloBAC11 
vector by selecting for Cm resistance, and for the seamless mini-F vector excision from the 
US unique AvrII site by the second en passant mutagenesis step (Figure 20).  
 
Figure 20. Mini-F vector transposition. Scheme of the transposition of the mini-F vector exemplified by the 
insertion into ORF22. First, the resistance gene cat of the pBeloBAC11 mini-F vector (green) of pHJO within 
the unique AvrII site of the US region was replaced by an aphAI-I-SceI cassette (blue) and a 50 bp direct viral 
sequence duplication (red arrows) via Red recombination (green and black dashed lines, first en passant step) 
resulting in pHJOFep. Second, the BAC vector pBeloSphI was inserted into ORF22 of pHJOFep via Red 
recombination (black dashed lines) using the transfer construct BeloSphI-HJO22-in and the present vector was 
removed from the unique US AvrII site via I-SceI induced double-strand break and Red-mediated recombination 
(red dashed lines, second en passant step) of the short duplications, to yield pHJOF22. 
In the mini-F vector transposition reaction, the pBeloBAC11 elements were inserted into 
ORF22, ORF50, or ORF54, and simultaneously removed from the US AvrII site by two 
successively induced Red recombinations combined with an interposed I-SceI double-strand 
break. For this procedure, the I-CeuI transfer constructs were released from the plasmids 
pBelo-HJO22-in, pBelo-HJO50-in, and pBelo-HJO54-in, and applied to introduce by Red 
recombination in GS1783 cells the pBeloSphI and pBeloBamHI BAC vector in inverse 
orientation with respect to the present aphAI-I-SceI-associated mini-F fragment into the 5‟-
end positions of ORF22, ORF50, or ORF54 within the cloned VZV genome of pHJOFep 
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(Figure 20). Upon induction of a double-strand break at the I-SceI recognition site, the aphAI-
I-SceI-linked pBeloBAC11 mini-F fragment was immediately removed in the second en 
passant step from the unique AvrII site of the US region by Red-mediated recombination of 
the short 50 bp genomic duplication adjoining the vector insertion site (Figure 20). The 
resulting BAC derivates of pHJO comprising pBeloBAC11 sequences in ORF22, ORF50, or 
ORF54 were termed pHJOF22, pHJOF50, or pHJOF54, respectively (Figure 20).  
Finally, I generated the transfer plasmids pEP-HJO22-DX-in, pEP-HJO22-DX-in, and pEP-
HJO22-DX-in to introduce corresponding genomic duplications into the pBeloBAC11 se-
quences of the derived pHJO variants. For this purpose, I used the 1.4 kb PCR products of the 
0.7 kb regions adjoining the 5‟-end positioned SphI or BamHI sites of ORF22, ORF50, or 
ORF54 that were generated with the primers K and L, M and N, or O and P (Table 1) and 
afterwards digested with SpeI for the generation of the mini-F vector transfer plasmids. These 
PCR products were cloned here in reverse orientation with respect to the pBeloBAC11 
sequences in pHJOF22, pHJOF50, or pHJOF54 into the AvrII site between the Belo 
fragments of the pEPMCS-in-Belo vector (Figure 11). The resulting plasmids were termed 
pEP-HJO22-DX-in, pEP-HJO22-DX-in, or pEP-HJO22-DX-in, respectively (Figure 21). 
 
Figure 21. Plasmids pEP-HJO22-DX-in, pEP-HJO22-DX-in, and pEP-HJO22-DX-in. For the construction 
of the plasmids pEP-HJO22-DX-in, pEP-HJO50-DX-in, or pEP-HJO22-DX-in, the 1,4 kb HJO sequences 
spanning the 5‟-end positioned SphI or BamHI site of ORF22, ORF50, or ORF54 were inserted into the 
universal transfer construct (green and blue) of plamid pEPMCS-in-Belo (Figure 11).  
Using the released I-CeuI fragments of the plasmids pEP-HJO22-DX-in, pEP-HJO50-DX-in, 
or pEP-HJO54-DX-in, the genomic duplications were introduced by en passant mutagenesis 
in GS1783 E. coli cells as described above (Figure 12) between the oriS and the cat gene of 
the pBeloBAC11 vector of pHJOF22, pHJOF50, or pHJOF54, resulting accordingly in the 
self-excisable constructs pHJOF22-DX, pHJOF50-DX, or pHJOF54-DX (Figure 22). Also 
these constructs could stably be propagated in E. coli GS1783 and enabled the mini-F vector 
removal and repair of the disrupted gene function by the two assumed events of homologous 
recombination in eukaryotic VZV-permissive cells (Figure 22).  
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Figure 22. Construction of pHJOF22-DX, pHJOF50-DX, and pHJOF54-DX. Upon mini-F transposition, the 
pBeloBAC11 elements were removed from the pHJO-cloned VZV genome and inserted into 5‟-end positions of 
ORF22, ORF50, or ORF54, resulting in pHJOF22, pHJOF50, or pHJOF54. Then, corresponding 1.4 kb genomic 
duplications of 0.7 kb viral sequences flanking the mini-F insertion site (a, b; c, d; e, f; yellow to red gradient 
bars) were inserted in inverse orientation into the pBeloBAC11 sequences, to generate pHJOF22-DX, pHJOF50-
DX, or pHJOF54-DX. Homologous recombination of the genomic duplications led to the excision of the vector 
sequences during the virus reconstitution in transfected eukaryotic cells. Primers P9 and P10, P11 and P12, or 
P13 and P14 were used to investigate the vector excision in virus progeny derived from pHJOF22-DX, 
pHJOF50-DX, or pHJOF54-DX, respectively. 
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4.3.2 Maintenance of the VZV genome during the mini-F vector transposition 
To confirm the integrity of the HJO genome organization, the transposition of the mini-F 
sequences and the insertion of the reverse genomic duplications, I prepared pHJO and 
pHJOFep as well as the three engineered pHJO variants and pHJO-DX constructs from the 
GS1783 E. coli cells, treated the BACs with HindIII, SalI, or BamHI, and compared the 
resulting RFLP pattern. All observed fragment rearrangements in pHJOF22, pHJOF50, or 
pHJOF54 in comparison to pHJOFep and pHJO were confirmed to correspond with the 
transposition of the pBeloBAC11 elements into ORF22, ORF50, or ORF54 and with the 
vector excision from the unique AvrII site of the VZV US region (Figure 23). Also the 
observed band shifts in pHJOF22-DX, pHJOF50-DX, or pHJOF54-DX in relation to 
pHJOF22, pHJOF50, or pHJOF54 correlated to the expected rearrangements by the insertion 
of the respective reverse genomic duplications into the pBeloBAC11 sequences (Figure 23).  
 
Figure 23. RFLP analysis of pHJOF22-DX, pHJOF50-DX, and pHJOF54-DX. Restriction fragment pattern 
of HindIII, SalI, or BamHI digested pHJO, pHJOFep, pHJOF22, pHJOF22-DX, pHJOF50, pHJOF50-DX, 
pHJOF54, or pHJOF54-DX BAC DNA. Fragments that comprise the pBeloBAC11 elements (green arrows), the 
restored unique AvrII site of the US region (red arrows), or sequences of the reverse genomic duplications (blue 
arrows) are marked. All fragment rearrangements of the engineered pHJO-DX constructs in comparison to the 
pHJO variants, and of the pHJO variants in comparison to pHJOFep and pHJO were observed as expected. 
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For instance, the genomic 7.6 kb Hind III fragment that contains the ORF54 appeared in 
pHJOF54 due to the insertion of the 6.4 kb pBeloSphI BAC vector, which lack a HindIII site 
in contrast to the vector elements of pHJO or pHJOFep, as a 14 kb band, and an additional 
12.5 kb band occurred that indicates the vector excision from the US AvrII site (Figure 23). 
The insertion of the reverse genomic duplication into the pBeloSphI elements within the 
ORF54 fragment causes a shift of the 14 kb band of pHJOF54 into a 15.4 kb band in 
pHJOF54-DX. Furthermore, the seamless repair of the unique AvrII site in all three pHJO 
variants was confirmed by PCR and sequencing analysis (data not shown). The transposition 
of the mini-F sequences into ORF22, ORF50, or ORF54 and the insertion of the corres-
ponding reverse genomic duplications in the pBeloBAC11 sequences in the three pHJO-DX 
variants were confirmed via PCR (data not shown). These results demonstrated that the 
pBeloBAC11 sequences were seamlessly transposed within the HJO genome into ORF22, 
ORF50, or ORF54 and that the integrity of the initially cloned viral DNA appeared to be 
conserved during the pBeloBAC11 insertion and excision reaction and subsequent integration 
of the reverse genomic duplications. In conclusion, a novel mini-F vector transposition 
reaction was established which enables the rapid, safe, and perfect restructuring of the 
infectious pHJO BAC in E. coli. 
4.3.3 Efficient vector excision from essential genes following delayed virus reconstitution 
In order to investigate the mini-F excision from the disrupted ORF22, ORF50, or ORF54 
upon virus reconstitution, I purified pHJOF22-DX, pHJOF50-DX, or pHJOF54-DX BAC 
DNA from E. coli and transfected the BACs into MeWo cells. In addition, to evaluate if the 
vector insertion into ORF22, ORF50, or ORF54 abrogates virus propagation, I also used the 
corresponding BAC variants pHJOF22, pHJOF50, and pHJO54 without inserted duplication 
for the transfection of the VZV-permissive cells. In comparison to the virus reconstitution 
from the original pHJO BAC, the formation of the VZV-typic CPEs in MeWo cultures 
transfected with the different pHJO-DX variants was detected only after one additional cell 
passage. As expected, CPEs were not detected in MeWo cultures transfected with the BAC 
variants pHJOF22 or pHJOF54 used as controls. In contrast, virus reconstitution from the 
control BAC pHJOF50 was detected directly after transfection of the MeWo cells without 
further passage of the MeWo cells. However, the plaques generated by the pHJOF50-derived 
progeny appeared to be smaller with VZV-atypical and indistinct syncytia formation in 
comparison to that provoked by HJO wild-type virus or all the other reconstituted viruses 
(data not shown). These resulted indicated that the insertion of the pBeloBAC11 sequences 
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into ORF22 or ORF54 apparently fully abrogated the virus propagation, whereas not 
completely when introduced into ORF50 and that the genomic duplication can reverse these 
detrimental effects. 
Finally, to determine the mini-F excision from the disrupted ORFs by the expected events of 
homologous recombination between the genomic duplications (Figure 22), the viruses recon-
stituted from the three pHJO-DX variants were propagated as described and DNA from the 
MeWo cells infected with the progenies of the different virus passages was prepared for PCR 
analysis. The primers P9 and P10, or P11 and P12, or P13 and P14 (Table 1) that annealed 
within the viral DNA exterior of the corresponding genomic duplication and up- or 
downstream of the mini-F insertion site of ORF22, ORF50, or ORF54 were used to determine 
the complete excision of the pBeloBAC11 elements in pHJOF22-DX-, pHJOF50-DX-, or 
pHJOF54-DX-derived progeny (Figure 22). To differentially analyze the retention or loss of 
the two pBeloBAC11 vector parts divided by the genomic duplications, I applied the 
introduced sopA and cat specific primers in the PCR (Figure 12). In all three recombinant 
progenies, the complete excision of the vector elements from the respective disrupted ORF 
was detected right upon virus reconstitution and not in the corresponding BACs used for the 
transfection of the MeWo cells (Figure 24). Remaining sopA or cat sequences were usually 
present until virus passage 4 after transfection of the MeWo cells (Figure 24). Thus, the 
duplication-mediated BAC self-excision from ORF22, ORF50, or ORF54 was more efficient 
than from the unique AvrII site. However, the vector sequences were, despite their highly 
impairing or abrogating effect on the virus replication, not immediately eliminated upon 
reconstitution of the viral progeny. In addition, the virus reconstitution from all three pHJO-
DX variants occurred with delayed kinetics. 
 
Figure 24. PCR analysis of the vector excision upon virus recovery from pHJOF22-DX, pHJOF50-DX, or 
pHJOF54-DX. PCR analysis of the pBeloBAC11 vector excision (F) or the retention of sopA or cat sequences 
in DNA from MeWo cells infected with pHJOF22-DX-, pHJOF50-DX-, or pHJOF54-DX-derived progeny of 
virus passage 2-5 using the indicated primers (P). Total DNA from MeWo cells infected with wild-type HJO or 
uninfected cells as well as BAC DNA of the three pHJO-DX variants were analyzed as controls. 
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4.4 Genome-intrinsic mini-F vector release  
Since the novel mini-F vector transposition reaction was based on Red recombination in E. 
coli, it allowed the rapid generation of BAC variants of the original pHJO clone independent-
ly from the viral DNA replication or genome maturation process. This initiated the possibility 
to develop pHJO variants comprising the mini-F vector sequences in specific genome 
positions that can be repaired by intrinsic VZV DNA replication mechanisms. We assumed 
that the mini-F elements of such engineered BACs can be efficiently and seamlessly released 
after virus reconstitution even without a genomic duplication. Moreover, the absence of a 
genomic duplication would additionally avoid the potential for illegitimate events of 
homologous recombination during the F-factor-mediated replication in bacteria or the viral 
DNA replication in eukaryotic cells. 
It was described that single deletion of the duplicated ORF62/71 that is located within the 
large S repeats and encodes the immediate-early transactivator IE62, leads to efficient repair 
of the disrupted repeat region by inherent homologous recombination events with the intact 
repeated region (Sato et al., 2003). Furthermore, it was surmised for the herpesvirus genome 
maturation process that the formation of the genomic termini is to some degree governed in-
dependently by two precise cleavages of a terminase complex coordinated from the two 
packaging signals (Figure 4) (Hodge and Stow, 2001; McVoy et al., 2000; Schynts et al., 
2003; Umene, 1999; Varmuza and Smiley, 1985; Wang et al., 2008). In addition, sequences at 
the genomic termini were believed to be recombinational hot-spots due to the induction of an 
additional double-strand break mechanism or due to the high GC content at the DNA ends 
(McVoy and Ramnarain, 2000; Mocarski et al., 1980; Severini et al., 1996; Slobedman et al., 
1999; Thiry et al., 2005; Umene, 1999). Therefore, we assumed that mini-F sequences 
inserted into one of the coding domains of the immediate-early transactivator IE62 or into the 
predominantly cleaved genomic terminal junction between the S and L component at the 
ORF0 end of the VZV UL region (S/L0), can be rapidly released by intrinsic DNA replication 
or genome maturation processes. Consequently, I planned to engineer pHJO variants 
comprising pBeloBAC11 elements in ORF62, ORF71, or the genomic terminal S/L0 junction. 
4.4.1 Mini-F transposition into duplicated genes or the terminal genome junction 
For the insertion of the pBeloBAC11 sequences into ORF62 of the TRS region, or into 
ORF71 of the IRS region, I developed the mini-F vector transfer plasmids pBelo-HJO62-in 
and pBelo-HJO71-in in the following cloning procedure. First, 1.4 kb HJO sequences of 0.7 
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kb regions that are found on either side of a BamHI site in ORF62/71, were amplified from 
pHJO by PCR using the primers S and T, digested with SpeI and inserted into the XbaI site of 
the MCS between the I-CeuI sites of the pCeu2 vector (Tischer et al., 2007). Subsequently, the 
BAC vector pBeloBamHI was linearized with BamHI and introduced into the BamHI site of 
the pCeu2-cloned fragment of ORF62/71 in reverse or in forward orientation, to generate 
pBelo-HJO62-in and pBelo-HJO71-in, respectively (Figure 25).  
For the introduction of the pBeloBAC11 elements into the terminal S/L0 junction, I construc-
ted the transfer plasmid pBelo-HJOpac-in as follows. To generate a BamHI site directly be-
tween the DNA ends of the S and L component for the subsequent incorporation of the mini-F 
plasmid pBeloBamHI, 0.7 kb viral sequences of the S and the L0 terminus were amplified 
separately from pHJO via PCR with the primers U and V or primers W and X (Table 1), 
whereby primer W provides a BamHI site, treated with SalI or SpeI, and successively cloned 
into the XhoI or XbaI site between the I-CeuI sites of pCeu2. Then, the pBeloBamHI BAC 
vector was cleaved with BamHI and introduced in forward orientation into the engineered 
BamHI site directly between the DNA ends of the pCeu2 vector-cloned terminal S/L0 transi-
tion, resulting in pBelo-HJOpac-in (Figure 25).  
 
Figure 25. Mini-F vector transfer plasmids pBelo-HJO62-in, pBelo-HJO71-in, and pBelo-HJOpac-in. To 
construct pBelo-HJO62-in, pBelo-HJO71-in, or pBelo-HJOpac-in, the pBeloBAC11 sequences were inserted 
into the BamHI site of the pCeu2-cloned fragments of ORF62/71 in forward or reverse orientation or into the 
cloned the terminal S/L0 transition.  
The generated plasmids were used for the transposition reaction to move the mini-F sequences 
into ORF62, ORF71, or the terminal genomic junction of the BAC-cloned HJO genome. For 
this procedure, the plasmids pBelo-HJO62-in, pBelo-HJO71-in, or pBelo-HJOpac-in were 
digested with I-CeuI and the released fragments were used to insert the pBeloBamHI vector 
into ORF62, ORF71, or the S/L junction of the en passant mini-F excision-ready BAC 
pHJOFep via Red recombination in E. coli GS1783 in inverse orientation with respect to the 
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pre-existing aphAI-I-SceI-associated pBeloBAC11 fragment in the US AvrII site (Figure 20). 
As described before, the pre-existing aphAI-I-SceI linked mini-F replicon at the unique AvrII 
site of the VZV US region was subsequently excised after I-sceI- and red-expression during 
the second en passant step (Figure 20). The resulting BAC constructs with pBeloBamHI 
vector in the ORF62 of the TRS region, in ORF71 of the IRS region, or in the S/L0 terminal 
junction between the two packaging signals at the ORF0 end of the UL region, were termed 
pHJOF62, pHJOF71, or pHJOFpac (Figure 26).  
 
Figure 26. Generation of pHJOF62, pHJOF71, and pHJOFpac. Upon mini-F sequence transposition, the 
pBeloBAC11 elements (green) were removed from the pHJO-cloned VZV genome and inserted into ORF62, 
ORF71, or the terminal genomic junction at the ORF0 end or the UL region, resulting in pHJOF62, pHJOF71 or 
pHJOFpac. After transfection of the BACs into VZV-permissive cells and virus reconstitution, the pBeloBAC11 
elements were released by inherent genome replication mechanisms. Primers P15 and P16, P15 and P17, or P18 
and P19 were used to verify the vector excision from ORF62, ORF71, or the terminal genomic junction. 
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4.4.2 Preservation of the VZV DNA after BAC transposition into repeated regions 
To confirm the integrity of the originally cloned HJO DNA as well as the transposition of the 
mini-F sequences into ORF62, ORF71, or the S/L0 terminal transition, I compared the SalI, 
PvuII, SphI, or BamHI RFLPs of the engineered pHJO variants with that of the original pHJO 
BAC and pHJOFep. The restriction fragment patterns of pHJOF62, pHJOF71, and pHJOFpac 
BAC DNA in relation to pHJO and pHJOFep were confirmed to correlate with the band shifts 
that were expected by the insertion of the pBeloBAC11 sequences into ORF62 of the TRS re-
gion, into ORF71 of the IRS region, or into the S/L0 terminal localization, and by the removal 
of the vector elements from the US unique AvrII site (Figure 27). For example, the 3 kb SalI 
fragment of pHJO and pHJOep that represents the terminal S/L0 transition appears in 
pHJOFpac as a 9.4 kb band by the integration of the 6.4 kb pBeloBamHI vector, which did 
not contain an additional SalI site in contrast to the vector sequences of pHJO and pHJOFep. 
Furthermore, the expected 2.6 kb HJO genomic SalI fragment encompassing the restored 
unique US AvrII site was detected in pHJOFpac BAC DNA (Figure 27).  
 
Figure 27. RFLP analysis of pHJOFpac pHJOF71, and pHJOF62. Restriction fragment patterns of SalI, 
PvuII, SphI, or BamHI digested pHJO, pHJOFep, pHJOFpac, pHJOF71, or pHJOF62 BAC DNA. Fragments 
containing vector sequences (green arrows) or the restored unique AvrII site of the VZV US region (red arrows) 
are indicated. All fragment rearrangements in the three pHJO variants in comparison to pHJO and pHJOFep 
were observed as expected. 
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These results and, thus, the stability of the pHJOFpac clone during the mini-F replicon media-
ted BAC replication in E. coli could also be confirmed by Southern-blot hybridization (see 
section 4.4.6). In addition, the scarless repair of the unique AvrII site as well as the 
pBeloBAC11 insertion into ORF62, ORF71, or the S/L0 transition in pHJOF62, pHJOF71, or 
pHJOFpac was confirmed via PCR and sequencing analysis (data not shown). Thus, the 
cloned HJO genome was fully maintained during the mini-F sequence transposition reaction 
to generate the pHJOF62, pHJOF71, or the pHJOFpac BAC construct. These results demon-
strated that the mini-F transposition reaction also allows the movement of the pBeloBAC11 
sequences into repeated domains of the cloned HJO genome in E. coli. 
4.4.3 Efficient intrinsic BAC vector release from the genomic junction  
In order to determine the proposed intrinsic vector release from ORF62, ORF71, or the termi-
nal S/L0 transition upon recovery of recombinant progeny, I isolated pHJOF62, pHJOF71, or 
pHJOFpac BAC DNA from the E. coli GS1783 cells and transfected the BACs into MeWo 
cells. VZV-characteristic focal CPEs were detected in the MeWo monolayers four to five 
days after transfection of the cells with the three different pHJO variants. The reconstituted 
viruses were propagated as described before and DNA of MeWo cells infected with the 
passaged progeny was investigated via PCR. To specifically determine the complete excision 
of the pBeloBAC11 elements from ORF62 of the TRS region, from ORF71 of the IRS region, 
or from the terminal S/L transition at the ORF0 end of the UL region, I used the primers P15 
and P16, P15 and P17, or P18 and P19 (Table 1) in the PCR, that annealed on either side of 
the mini-F insertion position and of which one primer bound within the S repeats and the 
other in the UL region (Figure 26). Since the vector was not divided into two parts by a 
genomic duplication, the persistence of the pBeloBAC11 sequences in the viral DNA was 
only analyzed by the primers specific for the cat gene (Figure 12). 
In the recombinant progenies derived from pHJOF62 or pHJOF71, the cat sequences were 
detected via PCR until virus passage five or four (Figure 28). During propagation of virus 
progenies derived from two different clones of pHJOF62 or pHJOF71, the vector elements 
were present until virus passage seven and beyond or six (data not shown). In contrast, in the 
DNA of pHJOFpac-derived progeny the cat gene was always traceable only until virus 
passage two (Figure 28). However, PCR fragments that indicate the complete pBeloBAC11 
excision from the viral genomes were not only obtained from the viral DNA, but also in minor 
quantities from the pHJOFpac clone and in significant amounts from the pHJOF71 or the 
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pHJOF62 BAC DNA used for the transfection of the MeWo cells (Figure 28). This might 
indicate that the BAC sequences of the three pHJO variants were already excised in a portion 
of viral genomes during the F-factor mediated replication in E. coli. In contrast, corres-
ponding fragments that reflect the vector excision were not detected in the BAC DNA isolated 
from the GS1783 cells by RFLP analysis (Figure 27) and specifically for the pHJOFpac clone 
also not by Southern-blot hybridization (see section 4.4.6). For example, the 3 kb SalI 
fragment that would correspond with the mini-F excision from the unique AvrII site was not 
detectable in the restriction fragment pattern of pHJOFpac (Figure 27 and section 4.4.6). In 
addition, it was described for the investigation of the VZV repeat regions of infectious cosmid 
clones that false positive signals can be generated during PCR amplification, even if one 
primer anneals within the unique region (Figure 26) (Sato et al., 2003). Therefore, we 
concluded that the pBeloBAC11 sequences were efficiently released from the viral DNA only 
after the virus reconstitution from the three pHJO variants. Since the pBeloBAC11 sequences 
in virus derived from the pHJOFpac clone were much more efficiently released in comparison 
to that of all the other generated progenies, this viral BAC appeared to be the ideal candidate 
to rapidly generate vector-free VZV mutants.  
 
Figure 28. PCR analysis of the vector release in virus progeny derived from pHJOFpac, pHJOF71, or 
pHJOF62. PCR analysis of total DNA from MeWo cells infected with pHJOF71-, pHJOF62-, or pHJOFpac-
derived virus progeny of virus passage 1-6 or 1-3 for determination of the pBeloBAC11 vector release or the 
persistence of cat sequences using the designated primers (P). Total DNA of MeWo cells infected with HJO 
wild-type virus or uninfected cells as well as BAC DNA of the pHJO variants were analyzed as controls.  
4.4.4 Sequence inversions after insertion of the BAC vector into the terminal junction 
The PCR fragments from pHJOFpac which were generated with the primers P18 and P19 
(Figure 26) may indicate the excision of the pBeloBAC11 elements already during the DNA 
replication in E. coli (Figure 28). However, they could also result from the inversion of the 
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UL region by homologous recombination of the small inverted L repeats. Therefore, I tried to 
determine if the mini-F sequences were also present at the ORF61 end of the L component, 
which would result from the inversion of the UL region in pHJOFpac (Figure 29A). For this 
purpose, the purified pHJOFpac BAC DNA used for the transfection of MeWo cells to 
reconstitute recombinant progeny, as well as BAC DNA of the original pHJO clone as a 
negative control, were analyzed via PCR using the following primer pairs. To confirm the 
existence of the mini-F sequences at the ORF0 end of the L component (F-L0), I used the 
primer P20, which anneals in sense orientation on the pBeloBAC11 end at the TRL region, 
and the primer P19, which binds in antisense direction in ORF1 of the UL region (Figure 
29A). To detect the mini-F sequences at the ORF61 end of the L component (F-L61), I 
applied primers P19 and P21, which bound in sense orientation in ORF61 of the UL region 
(Figure 29A). The expected fragments of 1 kb (1020 bp or 1028 bp) were derived in 
significant amounts from pHJOFpac BAC when using the primers P19 and P20 for the 
detection of the F-L0 transition and in minor quantities also when using the primers P20 and 
P21 for the detection of the F-L62 transition (Figure 29B).  
 
Figure 29. PCR analysis of a putative UL inversion in pHJOFpac. A) Inversion of the UL region in BAC 
DNA of pHJOFpac in an overview of both S/L transitional SalI fragments. Fragment lengths and the ranges 
from the SalI sites to the S/L junctions (dotted line) are indicated. Also the binding positions of primers P18-P21 
are given. Primers P18 and P19 were used to analyze pBeloBAC11 excision from the S/L0 junction in pHJOF-
pac-derived virus. Primers P19 and P20 were used to verify the presence of the mini-F vector at the ORF0 end of 
the UL region (F-L0). Primers P20 and P21 were used to detect the existence of the mini-F vector at the ORF61 
end of the UL region (F-L61), which would be the result from the inversion of the UL region. B) PCR analysis 
of pHJOFpac DNA for confirmation of the F-L0 or the putative F-L61 transition as outlined in A using the given 
primes. BAC DNA of original pHJO was analyzed as control. 
These PCR results could indicate that the UL region rarely undergoes inversion by homolo-
gous recombination of the small inverted repeats during the low-copy mini-F replication in E. 
coli GS1783. As for the mini-F excision, the inversion of the UL region was not detectable in 
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the restriction fragment patterns of pHJOFpac BAC DNA prepared from E. coli. For example, 
the 12.5 kb and 3 kb SalI fragments that would result from the inversion of the UL region 
(Figure 29A), were neither detected via RFLP analysis (Figure 27), nor by Southern-blot 
hybridization (see section 4.4.6). Therefore, we concluded that the PCR results which may 
indicate UL inversion were also false positive signals possibly generated by annealing of the 
amplified repeat regions, as suggested before for the analysis of the mini-F excision (section 
4.4.3 and Figure 28) (Sato et al., 2003).  
4.4.5 Seamless intrinsic BAC vector release from the VZV DNA termini 
To confirm the seamless vector excision from the VZV DNA ends after virus reconstitution 
from pHJOFpac, I analyzed the terminal S/L0 junction of the derived mini-F vector-free 
progeny, termed rHJOpac-F‾, as follows. Due to nucleotide polymorphisms at the VZV DNA 
ends, it was not possible to define the sequence of the 1.6 kb fragments that were generated 
from the terminal S/L0 transition of rHJOpac-F‾ by PCR amplification of the DNA from 
infected MeWo cells with the primers P18 and P19 (Figure 26 and 28). Therefore, the 1.6 kb 
PCR products of the terminal junction from the MeWo cells infected with rHJOpac-F‾ or with 
HJO wild-type virus as positive control were first cloned into the pCR2.1-TOPO vector and 
subsequently analyzed via sequencing. The repair of the S/L0 transition was confirmed in 16 
cloned PCR fragments derived from rHJOpac-F‾ (Figure 30).  
 
Figure 30. Sequence analysis of the terminal genomic junction of rHJOpac-F‾. Sequence analysis of 16 
cloned PCR fragments that were generated with the primers P18 and P19 (Figure 26) of the S/L0 transition of 
rHJOpac-F‾ or wild-type HJO DNA from infected MeWo cells. The derived sequences were aligned to the 
sequence of the terminal S/L0 transition of the original pHJO clone (first line). The GC tract of the S/L0 junction 
(highlighted in gray) as well as L and S component sequences (dotted lines) are marked.  
A variability of the number of the GC base pairs (ranging from 3 to 8 GC bp) directly at the 
junction was detected in DNA of the recombinant progeny and HJO wild-type virus (Figure 
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30). The sequence variability at the S/L0 junction of rHJOpac-F‾ appeared to be less 
pronounced as in the case of wild-type HJO. In addition, the number of AT base pairs of the 
pac2 signal in DNA of rHJOpac-F‾ appeared more conserved than in DNA of wild-type HJO 
(data not shown). Short deletions directly at the S/L0 junctions were found in DNA of 
rHJOpac-F‾ and of HJO, which was additionally verified by screening of further cloned DNA 
fragments via PCR (data not shown). Thus, the vector sequences were seamlessly released 
from the genomic termini upon virus reconstitution from pHJOFpac, whereby the nucleotide 
polymorphisms directly at the junction and the pac2 signal in the vector free progeny was not 
as variable as in the case of the wild-type virus.  
4.4.6 Repair of the VZV genome upon vector release from the DNA termini 
To define the genome organization after the release of the vector elements from the DNA 
termini, I determined the restriction fragment patterns of the pHJOFpac-derived mini-F 
sequence-free progeny rHJOpac-F‾ via Southern-blot hybridization (Figure 31). For this 
purpose, I digested total DNA from MeWo cells infected with HJO wild-type virus or 
rHJOpac-F‾, and pHJO, pHJOFep, and pHJOFpac BAC DNA from E. coli GS1783 with SalI 
and PvuII and hybridized the resulting DNA-fragment to a probe specific for the S/L0 
transition (Figure 31A), for pHJO sequences, or for the pBeloBAC11 vector. All obtained 
restriction fragment pattern of the rHJOpac-F‾ genome were comparable to that of the HJO 
wild-type virus (Figure 31B). For example, the 3 kb SalI fragments that correlate with the 
repair of the genomic S/L0 transition and the 1.6 kb or 1.4 kb SalI fragments that correspond 
to free L0 and S termini of linearized VZV genomes were specifically detected with the S/L0 
probe in the DNA of rHJOpac-F‾, whereas not in pHJOFpac BAC DNA (Figure 31B). 
Moreover, pBeloBAC11 sequences were only detected in the RFLP pattern of the digested 
BAC DNAs and not in the virus DNA (Figure 31B). These results demonstrated that 
rHJOpac-F‾ generated from pHJOFpac exhibited genome properties that were indis-
tinguishable to that of the wild-type HJO virus. These result also confirmed that the mini-F 
sequences were efficiently released from the HJO genomic termini by intrinsic mechanisms 
during the VZV DNA replication upon virus reconstitution in eukaryotic cells and not during 
the F-factor mediated replication in E. coli GS1783 cells (Figures 28 and 29). In overall 
conclusion, the HJO genome organization was preserved during the entire BAC cloning and 
mini-F vector transposition procedure in E. coli and upon virus reconstitution from the 
pHJOFpac construct in eukaryotic cells. 
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Figure 31. Southern-blot analysis of pHJOFpac-derived progeny rHJOpac-F‾. A) Scheme of both S/L 
transitional SalI fragments of pHJOFpac and rHJOpac-F‾. Upon virus reconstitution from pHJOFpac, the pBelo-
BAC11 sequences (green) were released from the viral genome, resulting in the vector-free progeny rHJOpac-F‾ 
with restored terminal S/L0 junction. Fragment lengths and the distances from the SalI sites to the S/L junctions 
as well as indicators for L and S component sequences are given (dotted lines). Also the binding sites of the 
probe (red bars) used for Southern-blot analysis of the S/L0 transition are indicated. The probe was derived from 
PCR products generated with the primers P18 and P19. B) Southern-blot analysis for detection of S/L0 transitio-
nal (red bar in A), pHJO-, or pBeloBAC11-specific fragments in SalI or PvuII digested DNA from MeWo cells 
infected with HJO or rHJOpac-F‾, or in digested pHJO, pHJOFep, or pHJOFpac BAC DNA. The 3 kb and 6 kb 
Sal fragments that correlate to the genomic S/L61 or S/L0 transition, and the 1.6 kb and 1.4 kb Sal fragments that 
correspond to free L0 and S termini in viral DNA as given in A are marked. Also the fragments comprising the 
unique AvrII site of the VZV US region or pBeloBAC11 sequences are indicated (red or green arrows). 
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4.4.7 Wild-type virus-like replication kinetics after vector release from the DNA termini  
Finally, to exclude any detrimental effects on the viral propagation after release of the vector 
sequences from the DNA ends, I investigated the replication kinetics of the vector-free 
pHJOFpac-derived progeny rHJOpac-F‾. Therefore, in parallel and quantitatively synchro-
nized experiments, I inoculated MeWo cells with cell-associated HJO wild-type virus or 
rHJOpac-F‾, and determined by titration the amount of plaque forming units (PFU) generated 
at 1-5 days post infection (d.p.i.). The obtained growth curves of rHJOpac-F‾ were 
comparable to that of the wild-type virus HJO (Figure 32). These results revealed that 
pHJOFpac allowed the rapid generation of recombinant progeny that exhibited indistingui-
shable replication kinetics to that of the wild-type virus. 
 
Figure 32. Growth kinetics of rHJOpac-F‾. Multistep growth kinetics of recombinant rHJOpac-F‾ in 
comparison to wild-type HJO upon propagation in MeWo cells. The plaque forming units per ml (PFU/ml) 
generated 1-5 days post infection (d.p.i.) are indicated. Means and standard deviations of two independent 
experiments are depicted. A picture of a virus plaque is shown on the right after staining by immunofluorescence 
for VZV glycoprotein I 3 d.p.i. of subconfluent MeWo cells with the titrated inoculum.  
Discussion 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
54 
5. Discussion 
Herpesvirus genomes engineered as infectious BACs are well-established and widely-used 
plasmid constructs to facilitate the generation of mutant virus progeny for functional investi-
gations. The large viral genomes can be maintained by the low-copy mini-F replicon as a 
“sleeping beauty” in E coli, seamlessly manipulated by versatile bacterial recombination 
techniques and subsequently shuttled into virus-permissive cells, where consistent viral popu-
lations are reconstituted in a reliable and safe manner (Brune et al., 2000; Messerle et al., 
1997; Wagner et al., 2002). However, whenever bacterial sequences are used to manipulate 
viral genomes, the overall effect on virus replication of introduced, foreign sequence scars, 
such as the mini-F cassette itself, is unpredictable. In this project, I introduced novel proce-
dures that allow the efficient and seamless excision of the bacterial vector sequences after 
virus reconstitution from two independently established infectious VZV BACs. These novel 
techniques, in addition to the recently developed markerless Red-recombination-based muta-
genesis methods in E. coli (Sawitzke et al., 2007; Sharan et al., 2009; Tischer et al., 2009; 
Tischer et al., 2006; Warming et al., 2005), resolve the last major problem for the rapid gene-
ration of mutant herpesvirus progeny without leaving behind any unwanted operational 
sequences in the manipulated viral genomes.  
5.1 Mini-F vector self-excision by stabilized genomic duplication 
In the first part of my thesis, I established a novel strategy for the seamless removal of the 
bacterial sequences from the BAC-cloned VZV genomes during the virus reconstitution in 
eukaryotic cells by homologous recombination of genomic duplications. This newly develop-
ed system applying duplicated viral sequences from both sides of the mini-F integration site 
between the origin of replication and the selection marker allowed the stable maintenance of 
the cloned herpesvirus genomes in Red-recombination-competent E. coli, such as GS1783 
(Figure 10). These herpesvirus BACs can therefore be manipulated by virtually every mutage-
nesis technique that is based on Red-recombination or ET cloning. 
Previous strategies to completely remove the mini-F sequences after virus reconstitution from 
herpesvirus BACs by homologous recombination were based on genomic duplications engi-
neered in direct orientation at either site of the bacterial vector elements (Strive et al., 2007; 
Wagner et al., 1999). However, these BACs can apparently not be stably propagated in E. coli 
harbouring the temperature-inducible expression cassette for the Red recombination system 
on a defective prophage integrated into host chromosome (Lee et al., 2001). Although the 
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expression of the Red proteins is tightly controlled by a temperature-inducible promoter, rare 
recombination events of the duplicated viral sequences leading to the complete deletion of the 
BAC sequences can also occur in an uninduced state during the replication cycle of the 
bacteria. Therefore, to manipulate these BACs by Red-recombination or ET cloning, the 
required recombination proteins had to be temporarily provided on an additionally introduced 
plasmid, which also had to be easily curable from the bacteria after the mutagenesis procedure 
(Strive et al., 2007; Wagner et al., 1999). However, recombineering by expressing the Red 
functions from a plasmid appears to be 50 to 100-fold less efficient than the  prophage 
system (Lee et al., 2001; Muyrers et al., 1999; Narayanan et al., 1999; Yu et al., 2000). In 
addition, the temperature-controlled expression of the Red proteins from the plasmid confers a 
higher leakiness than the expression of the recombination functions from the  prophage 
system, leading to higher instability rates of the BACs during the manipulation process. 
Another problem during the Red manipulation procedure using plasmids is formed by the 
fact, that they are frequently lost from the bacteria, which can entail the complete failure of 
the intended recombination. Moreover, the steady selection for the expression plasmid or their 
incompatibility with other plasmids limits their use for specific recombineering strategies 
(Lee et al., 2001; Yu et al., 2000; Zhang et al., 1998). 
All these limitations appear not to be valid for the novel duplication-mediated self-excision 
system, since this strategy tolerates rare recombination events induced by the  prophage 
system during the replication cycle of the E. coli. Even 3 kb genomic duplications of 1.5 kb 
viral sequences adjoining the mini-F integration site that contained sequences of the large S 
repeats did not provoke any detectable instability on the propagation of the VZV BACs in E. 
coli GS1783 (Figures 16 and 17). Consequently, this novel self-excision strategy can 
presumably be applied in general for established infectious herpesvirus BACs independently 
of the organization and the complexity of the cloned viral genome. In addition, using the 
universal transfer plasmid pBeloMCS-in-Belo, respective genomic duplications can be easily 
engineered within the vector sequences of all herpesvirus BACs that have been constructed by 
usage of the pBeloBAC11 mini-F sequences (Figure 11) (Tischer et al., 2007).  
Dependent on the mini-F vector integration site within the cloned VZV genomes and the 
orientation of the genomic duplication within the vector, the novel self-excision strategy al-
lowed the efficient release of the BAC sequences during four virus passages, as demonstrated 
for the pP-Oka-DX construct (Figures 12 and 14). However, even 3 kb genomic duplications 
of 1.5 kb regions adjoining the vector integration site did not provide the efficient elimination 
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of the mini-F sequences from the VZV US unique AvrII site of the BAC-cloned HJO genome, 
independently of the orientation of the duplication (Figures 12, 14, 16, and 17).  
For the previous vector self-excision system, it was demonstrated that 0.5 kb genomic dupli-
cations flanking the bacterial vector elements in direct orientation on both sides, can efficien-
tly induce the elimination of the vector sequences after the virus reconstitution from an infec-
tious cytomegalovirus BAC in also four virus passages, only (Wagner et al., 1999). In addi-
tion, it had been shown for a canine herpesvirus BAC that 2.7 kb direct genomic duplications 
flanking the vector insertion site can induce the complete removal from the viral progeny 
during one round of replication (Strive et al., 2007). Therefore, the previous duplication-medi-
ated vector self-excision system appeared to be more efficient than the newly established one.  
However, the slow replication kinetics and the highly cell-associated growth of VZV allows 
the polyclonal propagation of virus particles within the same infected cell and from cell to cell 
in culture, which could significantly impair the separation of non-repaired genomes and vec-
tor-free genomes and, thus, the elimination of the BAC sequences from the reconstituted VZV 
populations. In addition, the relatively small herpesvirus genome of VZV may better tolerate 
the large mini-F cassette due to less limited packaging constraints in comparison for example 
to the large cytomegalovirus genome (Wagner et al., 1999). It might therefore be possible that 
the novel self-excision system is much more efficient for BACs of cell-free viruses, faster re-
plicating viruses, or viruses with larger genomes. To compare the efficacies of the novel dup-
lication-mediated vector self-excision system with the previous one, these systems had to be 
applied for the same herpesvirus BAC using identically sized duplicated sequences and tested 
in parallel and synchronized experiments in vitro. Even though the developed novel duplica-
tion-mediated vector-removal strategy can be easily applied to virtually every established 
herpesvirus BAC using the appropriate transfer plasmids, its efficacy has to be determined 
specifically for each of these engineered infectious clones separately, since it obviously 
depends heavily on the BAC vector integration site within the viral genome. However, this is 
presumably due for every other deletion strategy that is based on homologous recombination 
of engineered genomic duplications.  
Although larger forward or reverse genomic duplications were engineered within the vector 
elements of pHJO (Figures 12 and 16), the BAC sequences of pP-Oka were much more 
efficiently released by a corresponding reverse genomic duplication during the replication of 
the reconstituted progeny than in the HJO system (Figure 14). The main difference between 
these two BACs is the position of the bacterial mini-F replicon. In pP-Oka, the mini-F 
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element is located within the S repeats in approximately 200 bp distance from the US region, 
whereas that of pHJO is situated in the US region (Figure 9). Regarding the self-repair 
potential of the S repeats during VZV DNA replication (Sato et al., 2003), it might therefore 
be possible after virus recovery that the vector sequences are also released from pP-Oka in 
significant portions per se from the viral DNA even without the addition of a genomic 
duplication, and, thus, explain the rapid vector elimination after virus reconstitution from pP-
Oka-DX (Figures 12 and 14). 
It can also be assumed that regions of the S repeats promote homologous recombination more 
efficiently due to their high GC content, and the greater the GC content is within the genomic 
duplication, the more efficiently the vector sequences are released. However, these assump-
tions cannot explain why the removal of the resistance gene cat from the unique AvrII site of 
the US region after virus reconstitution from the corresponding pHJO-DX variants appeared 
to be significantly impaired in contrast to that of the sopA element (Figure 14). Since the 
vector resistance gene within the pHJO-DX variants is flanked by the duplicated S repeat 
sequences, but not the mini-F replicon, the cat sequences should be eliminated from the virus 
populations, in theory, with higher efficacy than the sopA sequences (Figure 12). Perhaps the 
duplicated sequences of the S repeats within the different pHJO variants mediate frequent 
inversion events of recombination that did not promote the vector excision and that also did 
not have a detrimental effect on the viral replication (Figure 12).  
This in turn does not explain why a reversely inserted duplication in comparison to directly 
oriented duplication within the BAC vector elements seemed to support the vector excision 
more efficiently after virus recovery from the different pHJO-DX constructs (Figures 12 and 
14). Regarding the required recombination events (Figure 10), the independent excision of the 
mini-F replicon and the resistance gene can be expected to be rather promoted by a directly 
inserted duplication than by a reversely introduced duplicated sequence within the BAC 
vector of pHJO (Figure 12). Therefore, it is surprising that the two vector parts separated by 
the genomic duplication were apparently non-detectable at different time points after virus 
reconstitution from pHJO-DX, whereas not from pHJO-DXfw (Figure 14). However, which 
parallel and/or antiparallel intra- and/or intermolecular recombination events eventually medi-
ate the vector excision during the complex herpesvirus replication processes is difficult to 
determine, especially when regarding the duplicated S repeats, which are then present as 
triplicates, totally (Figure 12). Nevertheless, a directly or reversely inserted duplication within 
the vector of an established VZV BAC can promote the seamless release of bacterial sequen-
ces, providing the reconstitution of VZV mutants with vector-free genomes. Plaque purifica-
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tion of virus progeny can be one option to enhance the vector removal from the viral DNA. 
However, this approach can be associated with the separation of illegitimately recombined 
genomes and, thus, entails laborious investigation experiments, which would render the 
pHJO-DX variants inappropriate for rapid mutant generation. 
In conclusion, pP-Oka-DX appeared to be a valuable tool to rapidly generate P-Oka mutant 
progeny without vector remainders and with correct genome structure (Figures 14 and 15). 
The pP-Oka-DX construct might be a valuable tool to precisely define the nucleotide 
variations that are responsible for the phenotype of the vaccine strain V-Oka, and, therefore, 
facilitate the development of a second generation strategy for varicella and zoster prevention. 
5.2 Duplication-mediated mini-F vector self-excision from essential genes 
In order to significantly enhance the duplication-mediated vector self-excision, I engineered 
variants of the original pHJO BAC comprising self-excisable mini-F elements with correspon-
ding inverse genomic duplications in genes putatively essential for the virus propagation in 
vitro (Figure 22). To achieve this aim, I established a novel synchronous Red-mediated mini-
F vector insertion and excision reaction which allowed the rapid, targeted, and seamless 
restructuring of the BAC-cloned herpesvirus genome in E. coli (Figure 20). Since the mini-F 
vector transposition reaction is target-sequence independent and based on Red-recombination, 
it appears to enable the rapid generation of virtually every rearranged variant of a BAC in E. 
coli under perfect preservation of the integrity of the cloned DNA. In the context of the 
recently introduced highly versatile and markerless recombineering techniques (Sawitzke et 
al., 2007; Sharan et al., 2009; Tischer et al., 2009; Tischer et al., 2006; Warming et al., 2005), 
this novel mini-F vector transposition reaction eliminates the last hurdle to rapidly perform 
any kinds of imaginable targeted seamless BAC modifications in E. coli. The mini-F 
transposition reaction can be therefore generally a valuable tool to optimize, reorganize, or 
repair other established BACs as well, which may have an immediate impact on the 
development of gene therapy or vaccine vectors (Adler et al., 2003; Brune et al., 2000; 
McGregor and Schleiss, 2001; Sparwasser and Eberl, 2007; Wagner et al., 2002). In addition, 
this may be also useful to facilitate the generation and optimization of specific targeting 
vectors for mutant animals, such as conditional knock-out mice (Copeland et al., 2001; 
Ristevski, 2005; Shizuya and Kouros-Mehr, 2001; Yang and Gong, 2005). 
The essential features of the two-step en passant mutagenesis (Tischer et al., 2009; Tischer et 
al., 2006) allowed the targeted insertion of a second mini-F vector into the putative essential 
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gene and the markerless removal of the pre-existing mini-F vector of the viral genome via two 
simultaneously induced Red recombinations combined with an intermediary I-SceI-induced 
double-strand break (Figure 20). However, it is not clear when actually the second mini-F 
vector recombines with the cloned VZV genome and when the present vector is excised from 
the viral DNA. Eventually, it can also be surmised that the replication of intermediate mole-
cules with two mini-F replicons is completely suppressed in E. coli, regarding that maximally 
two BAC copies can exist per bacterial cell (Shizuya et al., 1992; Shizuya and Kouros-Mehr, 
2001). However, the existence of non-replicating intermediates with two mini-F units seemed 
to be unlikely, since replication forks for sites of homologous recombination would not be 
originated and, consequently, there would be no potential for the excision of the present mini-
F vector. Alternatively, it might be possible that the insertion and excision events of the 
pBeloBAC11 sequences are conducted in parallel during the second Red recombination of the 
transposition reaction after inducing a double-strand break at the pre-existing vector (Figure 
20). A stable maintenance of putative intermediates with two F-factor replicons can neither be 
confirmed nor excluded, since recombinants after insertion of the second mini-F vector via 
the first Red recombination of the transposition reaction were not further investigated. Howe-
ver, the versatility and efficiency of the developed transposition technique was finally proved 
by shifting the mini-F vector into different unique and repeated regions distributed over a 
cloned herpesvirus genome, finally resulting in six rearranged and infectious BAC variants 
(Figures 22 and 26). 
The observation that viral progenies were reconstituted from pHJOF22-DX and pHJOF54-DX 
after further passaging the transfected cells and not from the BACs pHJOF22 and pHJOF54, 
indicates that the vector insertion into ORF22 or ORF54 completely abrogated virus replica-
tion and that this highly detrimental effect was neutralized after a short decay upon repair of 
the gene by homologous recombination of the genomic duplication (Figures 22 and 24). Con-
sequently, the VZV large tegument protein and the capsid portal protein encoded by ORF22 
or ORF54 might be indeed essential for the virus replication in vitro, which corresponds to 
their HSV-1 and PRV homologs. The absence
 
of the large tegument protein of HSV-1 and 
PRV results in accumulation of DNA-filled non-enveloped
 
capsids in the cytoplasm and the 
nucleus; these capsids appear unable to traffic
 
to the site of secondary envelopment and to 
acquire tegument (Desai, 2000; Fuchs et al., 2004; Luxton et al., 2006). In addition, the VZV 
ORF54 homolog of HSV-1 forms a portal for entry of DNA into preformed capsids and is 
dispensable for the capsid assembly, but essential for the genome maturation and packaging 
process (Lamberti and Weller, 1996; Newcomb et al., 2001; Patel et al., 1996). In analogy to 
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these findings, it can be surmised that the viral particles reconstituted from pHJOF22-DX and 
pHJOF54-DX BAC DNA are only enveloped and tegumented, or filled with genomes after 
repair of the disrupted ORF by the recombination of the genomic duplications, and the 
infectivity can spread form cell to cell. The delayed virus reconstitution from pHJOF22-DX 
or pHJOF54-DX may then correspond to the time period required for the recombination 
events of the vector self-excision to restore ORF22 or ORF54. However, despite of the 
evident complete disruption of ORF22 or ORF54, it was interesting that remaining pBelo-
BAC11 sequences were detected in three further passages after virus reconstitution from 
pHJOF22-DX and pHJOF54-DX (Figure 24). This phenomenon may be explained by the 
highly cell-associated growth of VZV, which may cause an intimate polyclonal virus spread 
from cell to cell and, thus, allow the propagation of remaining pBeloBAC11 sequences upon 
trans-complementation (Grose et al., 1979; Harson and Grose, 1995; Weller, 1953).  
The result that virus was reconstituted from pHJOF50-DX and that small CPEs were detected 
also in cultures transfected with pHJOF50 indicated that the vector insertion into ORF50 is 
only slightly detrimental for the virus propagation and that the gene repair by homologous 
recombination is required for efficient replication of the virus. This conclusion corresponds to 
a recently introduced detailed study that VZV gM encoded by ORF50 is important for effi-
cient virus cell-to-cell spread in culture, but not essential for virus growth in vitro (Yamagishi 
et al., 2008). Although the vector insertion into ORF50 is apparently not completely abroga-
ting virus propagation, it was conflictive that the virus reconstitution from pHJOF50-DX was 
only detected after one further cell passage of the transfetced MeWo cells. Perhaps, the pre-
sence or an initial anti-parallel recombination event of the reverse duplication had an additio-
nal impairing effect on the virus propagation and that a second recombination event might be 
required to overcome this detrimental impact on the virus replication.  
In theory, just one recombination event should lead to the repair of ORF50 or ORF54 in 
pHJOF50-DX or pHJOF54-DX-derived progeny (between the duplicated fragments c or e, 
Figure 22), whereas two recombinations should be necessary to restore ORF22 in virus recon-
stituted from pHJOF22-DX (Figure 22). With regard of this different requirement for recom-
bination to restore the gene function, in addition to the discussed conclusions that ORF22 and 
ORF54 maybe essential for the virus propagation in vitro, it is surprising that the virus 
reconstitution from all three pHJO-DX variants was observed after one further passage of the 
transfected MeWo cells. It is also astonishing that an efficacy difference for the elimination of 
the pBeloBAC11 sequences was not detected in the three different recombinant progenies 
(Figure 24). More detailed, quantitative experiments would be needed to confirm these obser-
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vations and to define more profoundly the recombination mechanisms matching the findings. 
In summary, the three BACs pHJOF22-DX, pHJOF50-DX, and pHJOF54-DX allow the 
efficient vector release upon virus reconstitution, but appear to be suboptimal for further 
mutant generation, because the virus reconstitution occurs at delayed kinetics.  
5.3 Genome-intrinsic mini-F vector release  
Herpesvirus BAC construction via conventional or cosmid-based strategies includes recombi-
nation during the virus propagation in eukaryotic cells and transfer of circular replication 
intermediates into E. coli (Figure 7) (Messerle et al., 1997; Tischer et al., 2007). It is therefore 
presumably difficult to integrate the mini-F vector into repeated regions with self-repair 
potential or into sites involved in the viral genome replication or maturation process. Using 
the novel mini-F vector transposition method, which is completely independent from virus 
DNA replication, I developed the first herpesvirus BACs, of which the vector sequences were 
efficiently released by genome-intrinsic features during the genome maturation process, thus, 
without the need of additional sequences, such as loxP sites or genomic duplications (Figure 
26) (Smith and Enquist, 2000; Tischer et al., 2007; Wagner et al., 1999). This strategy to 
generate mutant herpesvirus progeny does not only avoid any remaining vector sequences in 
the viral genome, it also reduces the risk of illegitimate events of homologous recombination 
of the chimeric DNA during the bacterial or viral DNA replication. Finally, I identified the 
herpesviral terminal genomic junction as an optimal mini-F vector integration site for the 
construction of an infectious BAC that provides the rapid and spontaneous generation of 
recombinant progeny completely devoid of any bacterial vector elements (Figures 28, 30, 31, 
and 32). The terminal genomic junction might, therefore, be in general an optimal integration 
site of the mini-F sequences to construct other herpesvirus genomes or even other large linear 
viral DNA genomes as infectious BACs.  
The efficient vector release in virus recovered from pHJOF71 or pHJOF62 may indicate that 
ORF71 or ORF62 of the large S repeats was seamlessly repaired by inherent homologous re-
combination events during the viral DNA replication (Figures 26 and 28). This may support 
the previous detailed investigation of cosmid vector-generated VZV mutants that the single 
deletion of the S-repeated ORF62/71 encoding the major immediate early-transactivator IE62 
results in rapid repair of the disrupted region by recombination with the intact repeat (Sato et 
al., 2003). In addition, the observation that the vector sequences in viral progeny reconstituted 
from pHJOF62 were more rapidly released than in virus derived from pHJOF71, may 
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correspond to the former results that the ORF62/71 within the TRS regions can be more 
rapidly repaired than in the IRS region (Figure 28) (Sato et al., 2003). For this conclusion, it 
should be considered that the US region of the pHJO clones occurs in inverse orientation with 
respect to the UL segment regarding the defined VZV prototype arrangement (Figures 4 and 
9). However, to clearly confirm the repair of both repeats after virus reconstitution from 
pHJOF71 or pHJOF62, the viral genomes had to be analyzed in detail, for instance by 
Southern-blot hybridization. In addition, the seamless repair of the genomic sequence at the 
former mini-F vector insertion site within the ORF62/71 must be confirmed in both S repeats, 
to exclude any minor illegitimate homologous recombination events. 
The observation that the mini-F sequences in progeny reconstituted from pHJOFpac were 
much more efficiently released in comparison to that of all other generated recombinant viru-
ses may support the proposal that the vector sequences can be actively excised by a terminase 
complex from the genomic termini (Figures 26 and 28). This conclusion would then greatly 
support the general assumption that the formation of the herpesvirus genomic termini is to 
some degree governed independently from the two packaging signals (Hodge and Stow, 2001; 
McVoy et al., 2000; Schynts et al., 2003; Umene, 1999; Varmuza and Smiley, 1985; Wang et 
al., 2008). However, besides such an active cleavage mechanism, the mini-F vector excision 
from the genomic terminal S/L0 junction may also be achieved by highly frequent homo-
logous recombination, supported by a different double-strand break mechanism or by a high 
GC content (Thiry et al., 2005; Umene, 1999). Serially repetitive sequences that contain the 
packaging signals and that connect the S and L component at both junctions after circulariza-
tion of the HSV-1 genome are considered as recombinational hot-spots, but analogous ele-
ments are not present in VZV DNA (Dutch et al., 1995; Dutch et al., 1994; Mocarski et al., 
1980). The S and L repeats flanking the mini-F sequences at the disrupted S/L0 junction may 
recombine with the repeats at the intact S/L61 junction to release the vector sequences from 
the DNA of pHJOFpac-derived virus (Figures 29A and 31A). Both VZV repeats have a high 
GC content, but the L repeats are just 88 bp in length, making a highly efficient vector release 
by a non-induced homologous recombination process from the genomic termini rather unlike-
ly (Davison, 1984; Davison and Scott, 1986). The maintenance of non-repaired genomes 
within the first two passages of progeny generated from pHJOFpac (Figure 28) may be 
explained by rare genome maturation and packaging initiated from the S/L61 junction, 
encapsidating non-excised mini-F vector sequences within the S/L0 transition (Figures 5 and 
31A). In assumption that the vector excision is not a frequent incident during viral DNA 
replication, it may also be possible that the cleavage/packaging machinery prefers restored 
Discussion 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
63 
S/L0 transitions within concatemeric DNA, actively promoting the propagation of repaired 
genomes via a different mechanism (Figures 5 and 31A).  
In the performed experiments, I observed a genetic variability at the genomic junction upon 
VZV propagation in MeWo cells (Figure 30), reflecting mainly the situation in concatemeric 
DNA, which may correspond to the observation that VZV strains can express S/L proteins of 
varying length in vitro (Kemble et al., 2000). The slightly less pronounced variation of the GC 
base pairs tract directly at the S/L0 junction (Figure 30) or of the AT stretch of the pac2 signal 
in DNA of rHJOpac-F‾ in comparison to HJO may be explained by its clonal origin from the 
BAC template. Considering that DNA of rHJOpac-F‾ shows already after two virus passages 
nucleotide polymorphisms at the S/L0 transition, it can be assumed that the genetic 
constitution of the recombinant virus is upon further propagation adapted to the situation in 
DNA of wild-type HJO. The fact that virus reconstitution from pHJOFpac was not impaired 
in comparison to that from original pHJO may support the previous observation that the VZV 
S/L protein has a non-essential function in vitro (Kemble et al., 2000), and/or also indicate the 
immediate excision of the vector elements from the genomic termini.  
Although the stability of the two pHJOF62/71 variants and especially that of the pHJOFpac 
clone has been extensively confirmed by RFLP analysis, it appeared that rare mini-F excision 
or UL inversion within these BACs during their propagation in E. coli can be detected via 
PCR (Figures 28 and 29). Regarding the BAC arrangements of these three pHJO variants, 
inversion of the UL region seemed to be more likely than excision of the mini-F vector by 
homologous recombination of the inverted repeat elements (Figures 26, 29A and 31A). In 
fact, it appeared that inversion of the UL region in DNA of pHJOFpac can be confirmed via 
PCR (Figure 29). However, in context of the low-copy F-plasmid replication (Shizuya et al., 
1992; Shizuya and Kouros-Mehr, 2001), inversion of the UL region by recombination of the 
small L repeats seemed to be unlikely in BAC DNA of pHJOFpac, although the small L 
repeats have a high GC content. In addition, neither UL inversion, nor mini-F excision was 
specifically detectable via RFLP analysis in pHJOFpac (Figures 27 and 31B) or the 
pHJOF62/71 variants (Figure 27), even not during further manipulation of the pHJOFpac 
clone using Red recombination (data not shown). In conclusion, the PCR products that should 
prove the UL inversion (Figure 29) or mini-F excision (Figure 28) in the BACs are most 
likely be explained by super-primer formation (“mega priming”) during PCR amplification 
generating false-positive signals, a phenomenon already described in a similar way for the 
analysis of infectious VZV cosmid clones (Figure 33) (Sato et al., 2003). 
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Figure 33. Mega-priming hypothesis. Schematic depiction of super primer formation during PCR amplification 
of pHJOFpac exemplified for primers P18 and P19 in a detailed overview of both S/L transitional SalI frag-
ments. As primer P18 binds within the S repeats, its extension in a PCR adjusted for 2 kb polymerizations leads 
to two different oligonucleotides comprising TRS and pBeloBAC11 sequences (cat), or IRS, IRL, and sequences 
of the ORF61 end of the UL region. Primer P19 binds reversely within the ORF0 end of the UL region and its 
extension leads to the generation of oligomeres with ORF0-1 sequences, TRL and elements of the pBeloBAC11 
vector. Unprocessed oligonucleotides derived by extension of primers P18 or P19, containing reverse comple-
mentary IRL and TRL sequences at its 3‟-ends, may anneal with the BAC template (dotted arrows 1 and 4), with 
processed amplificates (dotted arrows 2 and 5), or even with one another (dotted arrow 3) to act as super primer 
during PCR amplification (mega-priming). Independently of the annealing reaction, further PCR amplification 
leads to the generation of DNA fragments of exactly the same size and sequence of the DNA fragments resulting 
from possible mini-F excision or UL inversion within pHJOFpac. Also the PCR product that can be generated by 
mega-priming using the primers P20 and P21 and deceive UL inversion are shown (framed box).  
Nevertheless, it may also be possible that a minor proportion of UL segments were indeed 
inverted, or that even the mini-F sequences were excised from the viral DNA already upon 
BAC propagation in E. coli and that these small amounts were only detectable via PCR and 
not by RFLP analysis. Inversion of the UL region in the two pHJOF62/71 variants should 
theoretically not have a detrimental effect on the virus reconstitution, since the genome orga-
nization of the viral DNA is retained after such an event (Figure 26). In addition, minor pro-
portions of BAC-vector sequences that have lost the viral insert DNA can be neglected in 
transfection experiments. This is also the case for the pHJOFpac clone, but UL inversion 
during propagation of this BAC should result in the positioning of the mini-F sequences at the 
occasionally cleaved S/L61 junction (Figures 29 and 31A) (Davison, 1984; Ecker and Hyman, 
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1982; Kinchington et al., 1985), which may have an influence on the efficiency of the vector 
excision after virus reconstitution. 
Regarding that both unique region regions can invert frequently during VZV DNA replication 
(Davison, 1984; Schynts et al., 2003; Slobedman and Simmons, 1997), in addition to the 
super-primer formation hypothesis (Figure 33) (Sato et al., 2003), it is presumably impossible 
to determine unambiguously via PCR in infected cells the mini-F vector excision and the 
repair of the interrupted repeat after virus reconstitution from the three pHJO variants (Figure 
26). The obtained PCR fragments that should prove the vector excision after virus reconstitu-
tion could therefore not be accepted as the only indication for the repair of the investigated 
VZV region (Figure 28). In this context, only conventional Southern-blot analysis allowed the 
clarification of the integrity of the effected repeat region (Figure 31B). 
All three engineered pHJO variants (Figure 26) could stably be propagated in E. coli and 
enable the efficient intrinsic vector excision after virus reconstitution (Figure 28), accepting 
them as valuable tools to generate VZV mutants without leaving behind any operational se-
quences. The pHJOFpac clone proved to be the infectious BAC which is most efficiently for 
the spontaneous generation of recombinant VZV that is virtually identical to HJO wild-type 
virus (Figures 28, 30, 31, and 32). Moreover, the versatility of pHJOFpac has already been 
proven by the generation of different vector-free GFP-fusion VZV mutants and by the deve-
lopment of a BAC chimera with a recombinant HJO/V-Oka VZV genome (Tanja Krater and 
Anne-Kathrin Brunnemann, data not shown). Thus, pHJOFpac is a novel and highly efficient 
tool for the rapid and targeted generation of VZV mutants without any secondary genome 
alterations. In conclusion, this BAC should facilitate the precise investigation of the 
nucleotide variations that might be responsible for the pain induction during herpes zoster. 
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6. Materials and Methods 
6.1 Molecular biology techniques and bacterial strains 
6.1.1 DNA preparation  
For analysis and cloning procedures, plasmids and BACs were isolated from E. coli by alka-
line lysis (Birnboim and Doly, 1979). Bacteria harbouring the constructs were grown over-
night in 5 ml Luria Bertani broth (LB) medium (5 g/l yeast extract, 10 g/l tryptone, 10 g/l 
NaCl) with appropriate antibiotics 30 µg/ml Cm,
 
35 µg/ml kanamycin (Kan), and/or 100 
µg/ml ampicillin (Amp) at 32°C (GS1783) or 37°C (XL-1 Blue, Stratagene, Amsterdam, The 
Netherlands; DH5α, Invitrogen, Karlsruhe, Germany) until the static phase was reached and 
then pelleted by centrifugation at 3,000 x g. The pellet was resuspended in 300 µl of solution I 
(50 mM Tris-hydroxymethyl-aminomethan (Tris)-HCl (pH 8.0), 10 mM ethylenediamine-
tetraacetic acid (EDTA), and 100 µg/ml ribonuclease A; stored at 2-8°C). For bacterial lysis, 
300 µl of solution II (200 mM NaOH, 1% (w/v) sodium dodecyl sulfate (SDS)) were added to 
the suspension and the mixture was incubated for 4 min at room temperature. Immediately, 
300 µl of solution III (3 M potassium acetate, pH 5.5) were added to the mixture and the 
derived solution was incubated on ice for 10 min. Cell debris and genomic DNA were 
sedimented by centrifugation of the mixture at 16,000 x g and the supernatant was vigorously 
mixed with 600 µl isopropanol. The DNA was pelleted at 16,000 x g, washed with 500 µl 
70% ethanol, pelleted again, and finally resuspended in 50 µl H2O.  
BAC DNA for transfection or electroporation was prepared with the Plasmid Maxi Kit 
(Qiagen, Hilden, Germany) according to the manufacturer‟s instructions. The purified DNA 
was gently dissolved in 100-300 µl H2O and stored at at 4°C.  
For PCR analysis of viral DNA, approximately 1 x 10
6
 infected MeWo cells were resuspen-
ded in 100 µl of lysis buffer (500 mM KCl; 100 mM Tris-HCl, pH 8.3; 15 mM MgCl2; 0.01% 
(w/v) gelatin; 0.5% (v/v) Tween20; 0.7% (v/v) proteinase K). The suspension was incubated 
for 1.5-2 h at 56°C and finally for 10 min at 95°C for proteinase K inactivation. 
Total DNA from MeWo cells for Southern-blot analysis was purified with the DNeasy Blood 
& Tissue Kit (Qiagen). Approximately 5 x 10
6 
infected MeWo cells were prepared according 
to the manufacturer‟s instructions. The aqueous DNA solution was vigorously mixed with 
1/10 volumes of sodium acetate (pH 5.5) and 2 volumes of 100% ethanol. The mixture was 
placed for 30 min at -80°C and subsequently centrifuged at 16,000 x g. Finally, the DNA 
pellet was washed twice with 70% ethanol, centrifuged again, and dissolved in 20 µl H2O.  
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6.1.2 Polymerase chain reaction 
PCR was performed with Taq DNA polymerase (Fermentas, St. Leon-Rot, Germany) or 
Phusion polymerase (New England Biolabs, Frankfurt, Germany). Usually, 100-200 ng of 
purified DNA or 1 µl of the MeWo cell lysate were used for PCR in 50 µl volumes. The 
reaction mixes were adjusted to the final concentration of 0.02 U/µl enzyme, 200 µM of each 
deoxynucleotide triphosphate, 0.6 µM of both primer oligonucleotides, and 2 µM MgCl2 in 1 
x Taq buffer with (NH4)2SO4 or Phusion GC-reaction buffer when using Phusion-polymerase 
for the amplification of GC-rich regions; DMSO (5%) was added optionally. In reactions with 
Taq polymerase, DNA was amplified by the initial denaturation at 95°C for 10 min, 35 cycles 
of DNA denaturation at 95°C for 30 s, primer annealing at 50-70°C (standard at 55°C) for 30 
s and primer extension at 72°C for 60 s per 1 kb, and a final extension time for 10 min at 
72°C. When Phusion polymerase was used to amplify GC-rich regions, the PCR was 
performed by denaturation at 98°C for 30 s, 35 cycles of denaturation at 98°C for 10 s, 
annealing at 50-70°C for 30 s, and extension at 72°C for 15-30 s per 1 kb, and a final 
extension time at 98°C for 10 min. 
3.1.3 Oligonucleotides 
Table 1: Construction (A-X) and Detection (P1-P21) Primers 
Primer Sequence (5’- 3’) Primer  Sequence (5’- 3’) 
A ACTAGTGCTTCTGCGCACAATGCCACAG P1 ATTGGAAGCGACGTCGACAC 
B ACTAGTGAACGGTACTTCGCCGCCGCGC P2 TGTAACGCGCGTAATACAGATCG 
C ACTAGTATAAATCTGTTCGGTAACGTGG P3 TGGGGTTTCTTCTCAGGCTATC 
D ACTAGTTTAATTAAAACATACACCGGATAAAAGC P4 TTAACTCAGTTTCAATACGGTGCAG 
E GACTAGTATTGGAAGCGACGTCGACAC P5 TGCCACTCATCGCAGTACTG 
F GACTAGTTGTAATGGGGCGTGACTCTG P6 AGGCATTTCAGTCAGTTGCTC 
G TACGCTCGAGGATCCTACTCGAGGTCA P7 TGTAACGCGCGTAATACAGATCG 
H TGACCTCGAGTAGGATCCTCGAGCGTA P8 ACCTACGAGAGATCCTGACACCC 
I TACGCTCGAGCATGCTACTCGAGGTC P9 TCAATTTGACGGTGCCCTG 
J GACCTCGAGTAGCATGCTCGAGCGTA P10 TTCACGCATATAGCGTGTCTCC 
K ACTAGTTATGTGTGCTCTTGTTGATCTCCC P11 TAGCCGTAGCCTTGTGATG 
L ACTAGTAACTTGTAACGCGTATAAGTTCCG P12 ACGCCCTAATGACTGGTAG 
M ACTAGTATTAACACGTGTATATAATGCGCC P13 CGGTTTCGGTAATATCTCCAAC 
N ACTAGTATTGTGGGGGAGTATAATTGTCC P14 CGGACATTGAGCCTGTAGG 
O ACTAGTTATCGTTCTCGCCCATTATACG P15 TGGTTTCCAAGGCCAAGAG 
P ACTAGTTTTCCGCTAATTAAATAAACGGAG P16 CCATCCGAGCAGTAAACGAG 
Q 
ATAAATACCTGTGACGGAAGATCACTTCGCAGAATAAATA
AATCCCGATTTATTCAACAAAGCCACGT 
P17 
P18 
AGGAAGTCGGGTGTATTGG  
CTTCGACCCGTCTTCCTTCC 
R 
TTACGTTATTATTAAATAAAACATGTAGACATTATTAATA
ATCCTAGGAACAATCAAATCCATATTTGTAAGTTATGTTT
AACCCCTCCCTAGGGATAACAGGGTAATGCCAG 
P19 
P20 
P21 
AGGTGTTCGGGAATCTGATAGC 
TGCTGCTGTGTCCTGCTTATC 
TTGGCTGTTGGATGGACTC 
S GACTAGTTACACGTGATACTGAGACAAAGCG   
T GACTAGTGGGAGGATGAGGCTGTGAGA   
U 
V 
W 
X 
CGCGTCGACCCTGCCGCAGAACCACTCGTGC   
CGCGTCGACCCTAGGGGGCCCCCCTCCCGGGGT 
GACTAGTGGATCCAGGGGGGCCCAGCCCTCTC 
GACTAGTCGTCCGCGCAACTGAAAATG 
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6.1.4 Restriction enzyme digestion 
Independently of the template, 0.5 U/µl conventional endonuclease (Fermentas) or 0.25 U/µl 
of the homing endocuclease I-CeuI (New England Biolabs) were used in corresponding 1 x 
buffer conditions for DNA digestion at 37°C. For analytical approaches, approximately 200 
µg DNA of plasmids were cleaved in 10 µl volumes for 1-2 h, and 1 µg VZV BAC DNA or 
10 µg DNA purified from VZV infected cells were incubated in 20 µl digestion solutions for 
6-8 h. To prepare fragments or linearized vectors, up to 4 µg DNA were digested in 50 µl 
volumes for 3.5-6 h. 
6.1.5 Agarose-gel electrophoresis 
For RFLP analysis, length determination, and isolation of DNA fragments, the digested DNA 
or PCR products were separated by agarose gel-electrophoresis and visualized by ethidium-
bromide staining. Usually, the aqueous DNA solutions resulting from restriction enzyme 
digestion or PCR were loaded with 1/10 volumes of loading dye (50% v/v glycerol, 10 mM 
EDTA, and 2.5 mg/ml brome phenol blue) onto 0.8-1.2% agarose gels with 0.008% (v/v) 
ethidium bromide, and the DNA fragments were separated for 1 h at 120 V in TBE-buffer (89 
mM Tris-HCl, 2 mM EDTA, 89 mM Boric acid) and visualized under ultraviolet light using 
the LAS 3000 imaging system (Fuji, Tokyo, Japan). For RFLP analysis of digested VZV 
BAC DNA, fragments were electrophoretically separated at 30 V in 0.5-1% agarose gels with 
ethidium bromide for at least 16 h. For sequencing or subsequent cloning reactions, the 
desired DNA fragments were purified using the Nucleospin Extract Kit II (Macherey-Nagel, 
Düren, Germany) according to the manufacturer‟s instructions.  
6.1.6 Nucleotide sequencing 
DNA sequences were determined with the Sanger dideoxynucleotide chain termination 
reaction using BigDye version 1.1 (Applied Biosystems, Darmstadt, Germany). Nucleotide 
sequences of VZV BACs or DNA from MeWo cell lysates were determined by using 5-50 ng 
PCR products amplified from the region of interest and plasmid sequences were verified by 
using 150-300 ng DNA, to set up reactions in 10 µl volumes; plasmids were optionally 
linearized to facilitate sequencing of GC-rich regions. Reactions were adjusted to the final 
concentrations of 0.5 µM oligonucleotide, 0.5 x sequencing buffer, and 1/10 diluted BigDye 
v1.1. Polymerization reactions were performed by initial denaturation at 96°C for 1 min and 
25 cycles of denaturation at 96°C for 10 s, annealing at 50°C for 5 s, and extension at 60°C 
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for 4 min. Fragments were purified, separated, and analyzed by fluorescence detection accor-
ding to the manufacturer‟s recommendations.  
6.1.7 DNA cloning 
PCR fragments were either cloned directly via endonuclease recognition sites into the target 
vector or first via the TOPO TA Cloning Kit (Invitrogen) according to the manufacturer‟s 
instructions. For direct cloning, insert and vector DNA were mixed in a molar ratio of 3:1 (50-
400 ng of dephosphorylated vector DNA) in 20 µl volumes with 0.25 U/µl T4 DNA Ligase 
(Fermentas) and 1 x Rapid Ligation Buffer conditions, and ligated by incubation for 5-30 min 
at room temperature. To generate vector chimeras, the linearized plasmid and pBeloBAC11 
vector were ligated in a molar ratio of 1:1 (approximately 400 ng of dephosphorylated BAC 
vector) as described above. For dephosphorylation of linearized DNA (2-4 µg), pBeloBAC11 
vector fragments were incubated overnight and plasmids were treated for 1 h in 50 µl volumes 
adjusted to 0.02 U/µl calf-intestinal alkaline phosphatase (Fermentas) and 1 x appropriate 
reaction buffer. 
6.1.8 Transformation of bacteria 
For plasmid cloning, chemically competent E. coli DH5α or XL-1 Blue bacteria (Invitrogen) 
were transformed via the heat-shock method. Portions (25 µl) of the bacteria suspension were 
gently mixed with 2-4 µl of the ligation reaction or 50-100 ng plasmid DNA, placed on ice for 
20 min, heat-shocked for 45 s at 42°C in a water bath, immediately placed on ice and resus-
pended in 250 µl LB medium. Bacteria were grown for 1 h at 37°C and 10-100 µl volumes of 
the suspensions were streaked onto agar plates with antibiotics (30 µg/ml Cm,
 
35 µg/ml Kan, 
and/or 100 µg/ml Amp) to select for transformants by incubation at 37°C. 
To clone BAC DNA, electrocompetent E. coli GeneHogs (Invitrogen) or GS1783 (Tischer et 
al., 2009) were transformed via electroporation. The non-commercial E. coli cells GS1783 
were made competent as follows. Bacteria were grown overnight in 5 ml LB medium with 
antibiotics until static phase, diluted 1:20 in LB medium with antibiotics, grown until A600 of 
0.5-0.6, placed on ice for 20 min, washed three times by centrifugation at 4,500 x g for 5 min 
and resuspension in 10% glycerol in H2O, again sedimented and finally resuspended in 10% 
glycerol in H2O of 1/100 volume of the original culture. A 50 µl portion of the bacteria sus-
pension was either used immediately for electroporation or after storage at -80°C.  
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Then, the DNA was transformed into GS1783 or GeneHogs E. coli by a short electric shock. 
For this purpose, electrocompetent 50 µl bacteria were gently mixed with 1 µl ligation mix or 
200-400 ng purified BAC DNA in H2O, electroporated at 15 kV per cm, 25 µF, and 200 Ω, 
immediately placed on ice, and resuspended in 1 ml LB medium. Suspensions were grown at 
37°C for 1 h when transforming GeneHogs or at 32°C for 2 h when using GS1783, and 50-
200 µl volumes were streaked onto agar plates with corresponding antibiotics for transformant 
selection by incubation at 37°C or 32°C, respectively. 
6.1.9 Southern-blot hybridization 
Southern-blot hybridization was performed using the DIG High Prime DNA Labelling and 
Detection Starter Kit II (Roche, Mannheim, Germany). First, the digoxigenin-labelled DNA 
probes were generated as follows. Approximately 1-2 µg of eluted PCR fragments or sonica-
ted BAC DNA was resuspended in 16 µl H2O, denatured at 95°C in a water bath for 10 min, 
and immediately placed on ice. After denaturation, 4 µl DIG High Prime was added to the 
solution and labelled DNA fragments were generated overnight (16 h) by incubation of the 
mixture at 37°C. To stop the reaction, 2 µl 0.2 M EDTA (pH 8.0) were added and the solution 
was incubated for 10 min at 65°C. Subsequently, 2.5 µl of 4 M LiCl and 75 of absolute 
ethanol were added to the solution. The mixture was incubated for 30 min at -80°C and then 
centrifuged for 1 h at 16,000 x g. The DNA pellet was washed twice with 70% ethanol, 
sedimented again, and finally resuspended in 50 µl TE buffer (10 mM; Tris-HCl, pH 7.5; 1 
mM EDTA). The probe was titrated by serially diluting the dissolved labelled DNA 1/10 until 
reaching 10
-6
 and 1 µl of each dilution was transferred onto a positively charged nylon mem-
brane (Roche).  
The labelled DNA was detected as follows. The probed membrane was gently shaken for 5 
min in washing buffer (0.1 M maleic acid, 0.15 M NaCl; pH 7.5; 0.3% (v/v) Tween20), 45 
min incubated in maleic acid buffer (0.1 M maleic acid, 0.15 M NaCl; adjusted with NaOH to 
pH 7.5), 30 min incubated in maleic acid buffer with 1/10,000 diluted anti-digoxigenin 
antibody conjugated to alkaline phosphatase (anti-digoxigenin-AP), shaken twice for 15 min 
in washing buffer, equilibrated for 5 min in detection buffer (0.1 M Tris-HCl, 0.1 M NaCl; pH 
9.5), incubated in detection buffer with 1/100 diluted chemiluminescence substrate for alka-
line phosphatase solution and finally incubated after removal of the substrate for 10 min in 
day light. The labelled DNA was then visualized by chemiluminescence detection using the 
LAS 3000 imaging system. Based on experimental experience, 5 µl of the original probe 
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solution was used for the following hybridization reactions if a clear signal was still visual at 
the 10
-4
 dilution or accordingly 10-fold volume more or less if the last clear signal was 
emitted from a dilution higher or lower.  
Having adjusted the probe concentration, the Southern-blot hybridization was performed as 
follows. Approximately 1 µg BAC DNA or 10 µg total DNA from infected MeWo cells were 
digested and electrophoretically separated in a 1% agarose gel without ethidiumbromide as 
described above. To prepare the DNA for capillary transfer, the gel was irradiated for 3 min 
with ultraviolet light using the LAS 3000 imaging system, shaken for 30 min in H2O and for 
10 min in 0.25 N HCl (until the brome-phenol blue turned into yellow) and rinsed shortly in 
H2O. Then, the DNA was blotted from the agarose gel onto a positively charged nylon 
membrane by upward capillary DNA transfer overnight using alkaline transfer buffer (0.4 N 
NaOH with 1 M NaCl). After that, the membrane was dried, irradiated for 2.5 min with 
ultraviolet light to cross-link the DNA and prepared for hybridization by rinsing in DIG Easy 
Hyb at 45°C for 30 min. The digoxigenin-labelled probe was denatured for 10 min at 95°C in 
a waterbath, immediately transferred in pre-warmed 10 ml DIG Easy Hyb onto the membrane 
and hybridized to the blotted DNA fragments overnight by 45°C. For hybrid detection, the 
membrane was rinsed 2 x 10 min in 2 x SSC buffer (0.3 NaCl, 30 mM sodium citrate, pH 7.0) 
with 0.1% SDS at room temperature, washed 2 x 15 min in 0.1 x SSC with 0.1% SDS at 68°C 
and further treated for chemiluminescence visualization as described above for estimating the 
probe concentration. 
3.1.10 En passant mutagenesis 
Red-recombination-based en passant mutagenesis was performed as described before (Lee et 
al., 2001; Tischer et al., 2009; Tischer et al., 2006). Primers that provide sequences for 
homologous recombination were purified by polyacrylamide gel electrophoresis (Biomers, 
Ulm, Germany). Reactions were applied in E. coli GS1783, since they harbour an expression 
cassette for the phage λ Red proteins under a temperature-inducible promoter and an L-(+)-
arabinose-inducible I-sceI gene on a defective prophage integrated into the host genome 
(Tischer et al., 2009).  
To insert a genomic duplication into the mini-F vector of the VZV BAC (pP-Oka, pHJO or 
the pHJO variants; Figure 12 and 22), the en passant protocol was accomplished as follows. 
First, the duplication was introduced into the VZV BAC via the transfer construct (Figure 11 
and 21) by Red recombination (Figure 12). Therefore, E. coli GS1783 harboring the VZV 
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BAC were grown in LB with 30 µg/ml Cm overnight until static phase was reached, then 1/20 
diluted in LB with 30 µg/ml Cm and grown to A600 of 0.5 to 0.6. Then, the bacteria were 
shaken in a 42°C water bath for 15 min to induce the Red-genes and immediately chilled on 
ice for 20 min. Afterwards, the bacteria were washed three times by centrifugation at 4,500 x 
g for 5 min at 0°C and resuspension in 10% glycerol, sedimented again and finally 
resuspended in 1/100 volume 10% glycerol of the original culture. Bacteria suspensions were 
adjusted to 50 µl portions, which were either used directly for the recombination reaction or 
after storage at -80°C. Then, a 50 µl portion of the electro- and recombination competent 
GS1783 was mixed with 100-300 ng of the en passant construct, electroporated at 15 kV/cm, 
25 µF, and 200 Ω and resuspended in 1 ml pre-warmed LB without antibiotics. Bacteria were 
grown for 2 h at 32°C and streaked out in 50-200 µl volumes onto agar plates containing 35 
µg/ml Kan and 30 µg/ml Cm to select for recombinants with both resistance markers by 
incubation at 32°C.  
Having confirmed the correct insertion BAC mutants, the en passant reaction for the excision 
of the introduced selection marker was conducted by an I-SceI double-strand break-mediated 
second Red recombination (Figure 12). Bacteria clones from a fresh colony or 100 µl from a 
static phase overnight LB culture with 30 µg/ml Cm and 35 µg/ml Kan were transferred into 2 
ml LB with 30 µg/ml Cm and grown for 4 h at 32°C. Then, 2 ml LB with 30 µg/ml Cm and 
1% arabinose was added for I-sceI expression and the bacteria suspension was grown for 1 h 
at 32°C, incubated at 42°C in a shaken water bath for 30 min to express the Red proteins. 
Afterwards, the bacteria were grown at 32°C for 4 h and finally streaked out in 1-50 µl 
volumes on agar plates with 30 µg/ml Cm and 1% arabinose to favor the growth of clones 
with excised I-SceI site at 32°C. 
For the BAC vector transposition reaction (Figure 20), a novel en passant-based protocol was 
developed as follows. First, the vector resistance gene cat of the pHJO clone was substituted 
by the kanamycin resistance gene aphAI, an I-SceI site, and the 50 bp duplication of viral 
sequences by Red recombination using the prepared PCR construct as described above (see 
also Figure 20), but bacteria clones harboring recombinants (pHJOFep, Figure 20) were 
selected on agar plates with 35 µl/ml Kan, only.  
The vector insertion and excision reaction of the transposition procedure was performed via 
the following novel protocol, which includes two immediately following events of Red 
recombination and an I-SceI induced double-strand break (Figure 20). Therefore, E. coli 
GS1783 harboring pHJOFep (Figure 20) were prepared for Red recombination as outlined, 
Materials and Methods 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
73 
except that the used LB cultures contained 35 µg/ml Kan. Electro- and recombination-
competent bacteria (50 µl portions) were mixed with 100-300 ng of the mini-F transfer 
construct, electroporated with 15 kV per cm, 25 µF, and 200 Ω, resuspended in 1 ml LB 
without antibiotics and grown for 2 h at 32°C as usual. Then, the excision of the previous 
mini-F vector was promoted immediately. Therefore, 1 ml of pre-warmed (32°C) LB with 60 
µg/ml Cm and 1% arabinose was added to the E. coli culture to induce the expression of I-
sceI and to enable simultaneously the maintenance of recombinants with the newly inserted 
mini-F vector. Subsequently, bacteria were grown for 1 h at 32°C, incubated at 42°C for 30 
min in a waterbath shaker to express the Red-proteins again to enable the recombination of 
the short 50 bp genomic duplication flanking the BAC vector (Figure 20), grown for further 2 
h at 32°C and 50-200 µl volumes of the suspension were finally streaked onto agar plates with 
30 µg/ml Cm and 1% arabinose to select clones harboring recombinant DNA with novel mini-
F sequences by incubation at 32°C. 
6.2 Cell biology techniques and virus culture 
6.2.1 Virus and cell culture 
VZV-permissive melanoma cells (MeWo cells) were cultivated in Dulbecco’s Modified Eagle 
Essential Medium (DMEM; PAA, Cölbe, Germany) with 10% fetal bovine serum (FBS; 
PAA) and 1x penicillin/streptomycin (PAA) (D10 medium), at 37°C, 90% relative humidity, 
and 5% CO2, and splitted in a ratio of 1:4 to 1:5 when grown to confluent monolayers in 6-8 
day periods. Viruses were propagated in cultivated MeWo cells and passaged by cocultivation 
of infected cells in different ratios with 1:4 diluted uninfected cells of confluent monolayers to 
yield cultures with CPEs of 70-80% after 6-8 days. Infected cells of the different virus 
passages for PCR or Southern-blot analysis were harvested by trypsinization or scraping, 
respectively, resuspended in phosphate-buffered saline (PBS), sedimented at 350 x g and 
prepared as described above. 
6.2.2 Virus reconstitution 
Reconstitution of viruses was enabled by the transfection of MeWo cells with BAC DNA 
using Lipofectamine2000 (Invitrogen) according to the manufacturer‟s instructions. Transfec-
tion was performed in 6 well format with 4 µg of affinity chromatography purified BAC 
DNA. DNA-lipofectamine complexes were added to the cells in DMEM without L-glutamine. 
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Transfection medium was replaced after 24 h with D10 medium. The following day, cells 
from three wells were collected and dispersed onto a 6-fold larger culture area.  
6.2.3 Immunofluorescence 
VZV-infected cells (in 24-well format) were detected by indirect immunofluorescence stai-
ning. After medium removal, the cells were fixed for 20 min using 2% paraformaldehyde in 
PBS, permeabilized with 1% saponin in PBS for 5 min and blocked for 1 h with 10% FBS in 
PBS at RT. Following that, cells were incubated for 1 h in 100 µl PBS with 10% FBS, 0.02% 
sodium azide, and 1/500 diluted VZV-specific primary antibody (mouse monoclonal anti-
VZV glycoprotein I, anti-VZV gI, Millipore, Schwalbach, Deutschland) and incubated for 1 h 
in 100 µl of PBS with 10% FBS and 1/1000 diluted fluorescent coupled secondary antibody 
(Alexa 488-conjugated goat anti-mouse, Invitrogen). The cells were rinsed three times with 
PBS following each step. Fluorescence was visualized using the inverse microscope 
OLYMPUS IX81 (Olympus, Tokyo, Japan). 
6.2.4 Multi-step growth kinetics 
Growth curves of recombinant rHJOpac-F‾ in comparison to wild-type virus HJO were 
generated by titration of the amount of infectious progeny generated at defined time points 
after inoculating the same number of cells with equal quantity of plaque forming units (PFU). 
Since VZV replicates highly cell-associated, usually whole cells are used for PFU determina-
tion, whereby high standard deviations are common. First, inoculi were adjusted to 100 PFU 
of cell-associated virus. Therefore, MeWo cells (from cultures with ~70 to 80% CPE) infected 
with wild-type virus or the mutant virus were trypsinized, resuspended in D10 medium, 
pelleted at 350 x g, washed in PBS, and finally vigorously resuspended in FBS with 10% 
DMSO. At minimum, 10 x 1 ml portions were frozen at -80°C and kept there for at least 2 
days. A portion of each virus type was titrated in quadruplicate by generating accurately 
mixed serially 1/10 dilutions adjusted in D10 medium to 1 ml volumes, and 100 µl of each 
derived dilution was added to 2 x 10
5
 MeWo cells seeded one day before in 24-well formats. 
After three days of cultivation, plaques were counted by indirect immune fluorescence 
staining using anti-VZV gI primary antibody and Alexa 488-conjugated secondary antibody. 
Titers from three portions of each virus-type were determined to calculate the PFU per ml for 
the whole frozen virus charge by the geometric median in total of 3 x 4 counts.  
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Having elucidated the titers, the growth kinetics of the recombinant virus was analyzed in 
direct comparison to the wild-type virus. Therefore, one frozen portion of every virus type 
was used to accomplish six parallel inoculations using 100 PFU of cell-associated virus to 
infect 1 x 10
6
 MeWo cells, which have been seeded 24 h before in 6-well formats. Virus 
concentration of the used frozen portion was confirmed by adjusting four times 100 PFU with 
D10 medium to 1 ml volumes, which were then titrated as described above to calculate the 
actual amount of PFU for the used inoculum volumina. At days 1-5, infected cells of each 
well were washed gently with PBS, dispersed with 1 ml trypsin and resuspended in additional 
9 ml D10 medium, and 4 x 1 ml of the resulting 10 ml cell suspension were used for titer 
determination as outlined above. Three portions of each virus were used to generate a growth 
curve. In total, the average amount of PFU yielded at the defined time-points after inoculation 
was determined by 3 x 4 counts per day. The entire experiment was repeated using different 
charges of the same virus type and the final growth curve was averaged by 24 (2 x 3 x 4) 
counts for each day. 
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